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Abstract
The inportance of respiratory syncytial virus (RSV) as a pathogen for acute lower 
respiratory tract infections in young children has been evaluated in a series of studies 
undertaken in The Gambia, West Africa. During the years 1993 to 1996, RSV occurred 
in yearly outbreaks in the rainy seasoiL Mainly young children were affected, but the age 
distribution varied between years (median ages 3, 7, 8 , and 5 months in the 4 years 
respectively). The estimated «mmal incidence of RSV infection leading to admission to 
hospital was 2.3% for children under 1 year of age; the proportion of all ALRI 
admissions due to RSV 19%.
In a case control study of potential risk factors for severe RSV infection, it was found 
that cases came from larger or more crowded households than controls; risk was 
particularly associated with larger numbers of children in the age groiç 3-5 years living 
in the extended household. Cases more frequently had a sibling who had died than 
controls. Controls were more likely to have been exposed to smoke from cooking fires 
than cases. Other protective factors were fafiier’s nationahty and profession. Vegetables 
were included in the diet of controls more frrequently than in the diet of cases. The 
number of asthmatic mothers was small in both groups.
In a prospective cohort shufy which conpared RSV-ALRI cases with 2 control cohorts, 
it was found that the incidence of pneumonia was q)proximately 3% times higher in 
cases than in controls. For vdieezing, the rate was 7 times higher, but wheezing was less 
common than pneumonia. At 3 years of age, pneumonia and wheezing were uncommon 
in aU groiq)s. Incidence rates of ALRI were approximately twofold higher in the wet 
season than in the dry season.
Tn conclusiun, RSV is all important cause of ALRI leading to hospital admission hi the 
Gambia. Acute and subsequent morbidity is considerable, so prevention by vaccination 
would be worthwhile.
Chapter 1. Introduction
Acute respiratory infections are the main killer of children in developing 
countries, accounting for 4 million deaths in children unda- 5 years of age each 
year. Diarrhoeal illness, malaria in tropical regions and measles are the
next most important infections. Malnutrition contributes to the mortality of all 
these diseases. Almost all acute respiratory deaths are due to lower 
respiratory tract infections such as pneumonia and bronchiolitis. The main 
causative bacterial pathogens of pneumonia are Streptococcus pneumoniae and 
Haemophilus influenzae. Viruses have been identified as important causes of 
acute lower respiratory tract infection (ALRI) in several studies, but their 
contribution to mortality remains controversial. ^  Two main approaches to the 
management of ALRI in developing countries have been developed: prevention 
through vaccination, and case management with qrpropriate antibiotics and 
supportive therapy. Vaccines for the prevention of severe ARI which are 
available through the Expanded Programme of Immunisations are measles 
(which causes respiratory problems as part of the viral infection and through the 
subsequent immunosuppression which predisposes to acute bacterial infection) 
and pertussis vaccines. A vaccine against H. influenzae type b was found 
effective in The Gambia in the prevention of pneumonia, but its cost is high. 
Unconjugated vaccines against S. pneumoniae are effective in older children but 
are not used widely, whereas conjugated vaccines are currently under 
development and need evaluation in developing countries. Case management 
of ARI depends on the early identification of cases by peripheral health workers 
with limited training. It is based on the recognition of simple signs such as
respiratory rate and lower chest wall indrawing and the prescription of oral 
antibiotics for less severe cases and referral of more severe cases for inpatient
treatment.
Several studies have addressed the aetiology of ARI in the Gambia over the past 
15 years. i*23.75-77,i76.i87.i88.254 £gj.jy gtudies identified the causes of ARI in children
who presented to hospital and outpatient departments; S. pneumoniae and 
H. influenzae were identified as the main bacterial causes. Later studies looked 
at aetiology in the important subgroups of malnourished children and infants 
under 3 months of age. More recently, information has been collected about 
the bacterial aetiology of ARI as part of the preparations for a vaccine trial with 
a conjugate vaccine against S. pneumoniae in the Upper River Division of the 
Gambia, and during the course of a trial of a conjugate vaccine against H. 
influenzae type b. Results of these studies are summarised in Table 4 in the 
section “RSV in The Gambia”.
Early studies by Forgie et al. and the studies on the aetiology of ALRI in young 
infants and malnourished Gambian children suggested the importance of RSV. 
However, these studies were either short in duration or restricted to subgroups of 
children. Thus, it was considered important to perform a longer, more 
comprehensive study of the epidemiology of RSV infection in Gambian children 
to obtain information about seasonality, age distribution and clinical 
presentation. These data are essential to the planning of a future vaccine trial. 
Identification of cases of RSV infection during the course of the epidemiological
studies provided an opportunity to investigate potential risk factors for the
infection and to evaluate its long term sequelae. Thus, the series of studies
described in this thesis had the objectives outlined below.
1.1 Study objectives
• Description of the epidemiology of RSV infection in Gambian children based 
on surveillance of hospital cases of ALRI.
• Description of the community rate of infection with RSV in young children 
during outbreaks through visits to the compounds of index cases and controls.
• Description of the clinical spectrum of RSV infection among cases admitted 
to hospital, including the incidence of bacterial co-infection and outcome.
• Determination of the viral subtypes responsible for outbreaks, their 
relationship to viral strains found elsewhere, and their correlation with clinical 
severity.
• Identification of social and environmental risk factors for severe RSV 
infection.
• Determination of the firequency of subsequent respiratory infections in 
children who had been admitted to hospital with a severe RSV infection.
Chapter 2. A review of RSV infection in industriaiised and 
developing countries
2.1 The virus
2.1.1 History
RSV was identified first m 1956 in a group of chimpanzees and accordingly 
called chimpanzee coiyza agent (CCA). It was speculated at that time that the 
chimpanzees were probably infected from a laboratory woiker. Soon after, two 
agents indistinguishable fi'om CCA were recovered from infants with 
bronchopneumonia, and the common virus of all three strains renamed 
“Respiratory Syncytial Virus” (RSV). ^  Over the next four years, studies in the 
USA identified RSV as the most important cause of lower respiratory tract 
infection in children and the main cause of bronchiolitis. Further studies 
from all continents found RSV or serum antibodies against RSV wherever these
w e r e  s o u g h t .  2839.65,?2.91.123.166.177.183.200;219.220.240
2.1.2 Classification
Respiratory syncytial virus (RSV) is a medium sized enveloped RNA virus.
It is classified in the family of viruses called Paramyxoviridae, and in the genus 
Pneumovirus. Bovine respiratory syncytial virus, ovine respiratory 
syncytial virus, caprine respiratory syncytial virus, pneumonia virus of mice, and 
turkey rhinotracheitis virus also belong to this genus (Figure 1).
Figure 1. Relationship of viruses in the îasidlY  Paramyxoviridae, 
Adapted from Collins et al/^.
Paramyxoviridae
family
-  Sendai virus
-  human PIV 1
-  human PIV 3
— mumps virus measles virus
— simian virus 5
— Newcastle disease virus
— human PiV 2
— human PiV 4
-RSV
— bovine RSV
— caprine RSV
— ovine RSV
— pneumonia virus of mice 
—turkey rhinotracheitis vims
Rubulavlrus
genus
MorbillMrus
genus
Pneumovirus
genus
Paramyxovirus
genus
Paramyxovirinae
subfamily
Pneumovirinae
subfamily
Note: Caprine and ovine RSV are possibly only subgroups of bovine RSV rather than 
distinct viruses.  ^ PiV: Parainfluenza virus
The genome of RSV contains gaies for 10 main proteins. The two main 
surface proteins which are important for the generation of an immune response 
are the fusion protein (F protein, 70 KD) and the attachment glycoprotein (G 
protein, 90 KD). Two groups of RSV strains have been identified using 
monoclonal antibodies, which are called group A and group B. They differ 
predominantly in the G protein; the F protein is well conserved between
groups. 125-127
2.13 Characteristics
RSV is a relatively labile virus. At 4°C, only 1 percent of infectivity remains 
after 1 week. The virus withstands freezing and thawing poorly. In culture, 
RSV grows best in human diploid cell lines such as Hep-2  or HeLa cells.
The characteristic cytopathic effect of RSV in cell cultures is syncytia formation, 
from which the virus derives its name.‘^ °
RSV is predominantly a human virus. RSV has also been recovered from 
chimpanzees, cattle, goats, and sheep, but human RSV grows less well in 
ruminant cells than bovine RSV. Antibodies to RSV have been demonstrated 
in cats and dogs, however the meaning of this is unclear.
2.2 RSV infection in the industriaiised world
2.2.1 Epidemiology
RSV infection is strongly seasonal in temperate climates. Outbreaks occur 
mainly during the winter months, extending into spring, and occur regularly 
every year. 24.56.87.91,134,151,156,167,172,197,212,242 Outbreaks are usually sharp in Onset and
last between 2 and 5 months. In some settings outbreaks start early in one winter 
and late in the next winter.
The peak incidence of hospitalised cases of RSV is in the age group 2  to 5 
m o n t h s . S e r o l o g i c a l  studies suggest that about half of all children are 
infected during the first year of exposure, and that almost all have been infected 
after the second outbreak that they encountered. In Washington, DC,
40% of all RSV infections in the first year of Hfe involved the lower respiratory 
tract, and 1% of infected infants required admission to hospital. In Houston, 
Texas, 33% of the children with an RSV infection had a lower respiratory tract 
infection, and 1.6% required hospitalisation. Males generally predominate at a
ratio of 1.5-2:1 among children admitted to hospital, ‘*2.143.197 distribution
between sexes is more equal in müder cases. ‘*2.85.110.270
Re-infection with RSV is common. A study in Tecumseh, Michigan, found 20% 
of 5-9 year old children to be (re-)infected within a year. The rate fell to 10 
% in children 15-19 years old, and to 3 to 6% in adults between 20 and 50 years 
of age. RSV spreads effectively within families. The infection appears to 
be introduced by children of school age. Bigger families have a higher rate of 
infection. The incubation period of illness from RSV has been reported as being 
between 2 and 8 days, most commonly between 4 and 6 days. *^ '233.234
Z2.L1 RSV infection in elderly people
Recently, RSV has been recognised as an important pathogen in elderly people. 
Outbreaks have been described in nursing homes, affecting a high percentage of 
residents, with complications occurring in up to 15% of the infected persons. 
4.94,107 Epidemiological studies correlating RSV outbreaks with excess deaths 
from respiratory infections indicate that RSV might be as important a cause of 
increased mortality in elderly people as influenza. 21.25.74
2.2.L2 Factors associated with RSV disease and protection
The following table summarises the dynamics of infection with RSV and the 
factors associated with transmission of the virus and protection as described in 
the literature.
Table 1 : Factors associated with transmission of and protection against RSV.
Factor Findings and comment Reference
Vims
Source
Transmission and 
viability of the vims
Viability of the vims
Transmission
distance
Incubation period
Shedding of virus
Humaa, Isolated from ruminants, chirc^ianzees, but animals not believed to HaU
be important for transmission.
Large droplets, small droplets inactivated quickly. Redisteiner
Maximal stability at 60% humidity, less stable at 30% and 80% humidity. 208,209
R SV  in freshly obtained infant secretions was recovered from countertops for Hall 99  
up to 6 hr, from mbber gloves for up to 1 1/2 hr, from cloth gowns and paper 
tissue for 30—45 min, and from skin for up to 20 irdn.
No infection in volunteers more than 6 feet away from infected infiints. HaU 96
4-6 days most common. Ditchbum ^
(2-8 days as range) Sterner 234
Average 5 days in adult volunteers. Kravetz
The vims was died for prolonged periods. For the first seven days of HaU 97
hospitalisation, 92%-100% of the infants tested continued to shed virus. At 
discharge 87% were stiU shedding the vims.
The mean duration of shedding for 23 patients untU they were virus negative HaU 98 
was 6.7 days with a range of 1 to 21 days.
Immunity
Neonatal: maternal 
antibody
Breast milk
IgA in brvtuii imlk
Earlier infection in infants with low maternal antibody levels. Glezen
The risk of reinfection was inversely related to the level of neutralizing Glezen ®9
antibodies in the serum.
Mean titre of maternal IgG antibody to RSV was significantly higher (P less OgUvie 190
than 0.001) in mothers whose babies remained uninfected than in those 
whose babies had proven RSV infection before 6 monUis of age.
Sera frum a group of mothers whose babies escaped RSV infection during a 
local epidemic showed increased antibody levels to VPN41 when conpared 
to sera frum mothers whose babies had become infected with RSV within the 
first 6 months of fife. In infants Wio remained uninfected with RSV during 
the first 12 months of life the maternal gifi of antibody decayed to about 50% 
at 3 months with traces of antibodies detected in a few sem at 12 months. The 
antibody levels detected in the sera of infants less than 3 months old 
convalescent frum primary RSV infection did not exceed the mean levels 
present in the serum of uninfected babies.
Ward 257
Eight out of 115 infants admitted to hospital with RSV infection had been 
breast-fed conpared with 46 out of 167 controls.
Downham 68
IgA autivii^ antibody persisted in the m ilk of only four of 18 mothers. Toms 245
Similarly, antiviral IgG and IgM antibodies were not generaUy detected after 
the first post- partum week.
Table 1 et.
Factor Findings and comment Reference
Laegreid 144Neutralizing activity against RSV was measured in m ilk sanples from 17 
healthy women whose infants had an acute infection with RSV and from 27 
women with healthy infanta. All milk sanples were obtained 2-8 months post 
partum. Neutraliang activity was detected in 36 sanples. No major 
difierence in neutralising titres was observed between the two groups, and 
the titres were low.
Infection- and reinfection rates
Infection- and 
reinfection rates
Frequency of 
reinfection
Re-infection by age 
group
Re-infection of adults
Weotipn v/ithin
fam ilies
Subtypes
Crossprotection
Circulation
The infection rate was 68.8/100 children less than 12 months of age and 
82.6/100 during the second year of life. Virtually all children had been 
infected at least once by 24 months of age, and about one half had 
experienced two infections.
During epidemics the attack rate for first infection was 98 per cent The rate 
for second infections (75 per cent) was modestly reduced (P<0.001); that for 
third infections was 65 per cent 
Amelioration of illness in subsequent attadcs.
Glezen 89
Henderson
111
Monto 1675-9 years of age: 19.7%
10-14 years: 16.9%
15-19 years: 10.1%
adults: 3-6% re-infection per year.
15 adults with previous natural RSV infection were challenged with RSV of Hall 103
the mme strain group (A) at 2,4, 8,14, 20, and 26 months after natural
infection. By 2 months about one^udf and by 8 months two-thirds of the
subjects became reinfected. Within 26 months 73% had two or more and
47% had three or more infections. The duration of immunity tended to
increase after two closely spaced infections.
The virus infected 44.4 per cent of famUies, and 21.9 per cent of aU members. HaU 100
AU age groups had appreciable attack rates (with a range of 16.8 per cent in
adults to 29.4 per cent in infants). In infected famUies, 45.9 per cent of
members became infected, including 10 of 16 infants. Secondary attadc rate
for aU ages was 27 per cent, and that for infants 45.4 per cent An infant's
older sibling appeared most likely to introduce the virus into the famUy.
Infection with subgroup A strains of req)iratory syncytial virus provided 
some protection fiiom a second infection with the homologous, but not the 
heterologous, subgroup of the virus.
Primary group A infection eUcited antibodies cross-reactive with group B 
virus in the PRNB and the ELISAS for GB and FB. In contrast, primary 
group B infection induced significant increases in mean concentrations of 
antibody cross-reactive with group A virus only in the FA ELISA. Second 
RSV infections caused by group B viruses in chUdren with histories of 
primary group A infection induced heterologous rises in the PRNA and GA 
assays, suggesting that prior group A infection had primed for a more 
extensive axrss- reacting antibody response at the time of second RSV 
infections with group B viruses.
Three patterns of yeariy outbreaks existed in 15 sequential years:: (1) strong 
predominance of group A strains (9 years with 83%-100% A strains), (2) 
relatively equal proportions of group A and B strains (4 years), and (3) strong 
predominance of group B strains (78%-85%) in 2 years, separated by a 
decade. The first pattern of highly dummaut A slmhis uuuuired in cycles of 1 
or 2 consecutive years with a single intervening year in Wiich B strains were 
greater than or equal to 40% of the isolates.
Mufson 170
Muelenaer
169
HaU 104
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Table 1 et.
Factor Findings and comment Reference
SevCTity of digeaae
Lower re^iratory 
infections
Sex distribution
Although lower respiratory tract disease (LRD) was common (22.4/100 
during year 1 and 13.0/100 during year 2), most children had only one LRD 
lUiiéàà. Reiiiféctlûii ilLiesses were generally mild, and iiak of reinfection 
decreased to only 33.3/100 during year 4. Hospitalisation rate 1.6%.
West Virginia; 3.3 % hospitalised.
Immunity induced by a single infection had no demonstrable effect on illness 
associated with reinfection one year later, however, a considerable reduction 
in severity occurred with the third infection.
First year of life: 40% ALRI, 1% hospitalised.
The maximum yearly admission rate occurred among infants aged 1 to 3 
months: 24.5 per 1000 of that age group were admitted to hospital, (industrial 
areas double the rate of rural).
North East England: 2% of under 1 year olds admitted.
1.8:1 male: female forLRI.
1.5:1 male : female forLRI.
Equal for mild infection.
Glezen 89
Belshe 26
Henderson
111
Brandt 33
Anonymous
11
Martin 1^3 
Glezen 85,86
Kim 134
Glezen 85,86
Risk factors
Crowding
Socio-economic class
Seasonality
Winter
Rainy season
Fluctuations between 
early and late 
outbreaks in 
different years
Missed outbreaks
Between 1 and 3 months of age, in multivariate analysis, only sex and the Holberg
number of others sharing the room remained as significant direct risk factors.
Being in day care was a significant risk factor in the 7- to 9^nonth age range.
Children living in electoral wards in the two more deprived groups were Spencer 231
more than 1.5 times as likely to be admitted (OR 1.67, 95%CI 1.25-2.24).
In tençerate climates. HaU
In most tropical climates with seasonal rain fall.
Early alternating with late, distance between peaks 15,7,14,11,13,12, 14, 9 Glezen 86
months.
Mardi/April 1979 then January 1980 (West Virginia). Belshe 26
Over 10 years alternating early/late outbreaks, Turku, Finland. Waris 258
Outbreak December followed by outbreak March (16 months). Wilcox 269
One year in Gambia. Forgie 25
29 months, B razil. de Arruda 59
Three years in sequence with very little activity (1972-74), Chapel Hül, N.C. Henderson
USA (?insensitive cell hnes). ^^3
1984/85 Huntington West Virginia USA. Mu&on 121
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2.2.2 Clinical features including long term complications
The first infection of an infant with RSV is almost always ^parent, but clinical 
features vary between a runny nose and severe pneumonia. Children who 
develop a lower respiratory illness may do so again in the following years, but 
these episodes are generally less severe. The most common manifestation 
of RSV-ALRI is pneumonia, the ratio between cases of pneumonia and 
bronchiolitis ranges between 7:1 and 1:1.®^  Often the signs of both entities 
overlap, and pneumonia appears to be a continuum of bronchiohtis.
Pathological changes in the lungs of children who have died of RSV 
bronchiolitis include a peri-bronchiolar mononuclear infiltration, necrosis of the 
epithelium of the small airways, plugging of the lumina of the small airways, and 
hyperinflation and atelectasis.  ^ The most common signs of RSV-ALRI are 
cough (97-100%), rhinitis (56-82%), dyspnoea (50-78%), rhonchi (59-78%), 
wheeze (45-76%) and crepitations (27-72%) Fever is less common in younger 
children than in older ones. ^ Clinical assessment of children is directed mainly 
at the detection of hypoxaemia. This is probably due to a low ventilation- 
perfusion ratio rather than to shunting through unventilated lung. Most
children admitted to hospital improve sufficiently within 4 to 7 days to be 
discharged, but inflammation in the lung may persist longer with abnormalities 
in gas exchange and wheezing.
A few children require intensive care treatment with intubation, most commonly 
those with underlying illnesses such as lung disease of prematurity or congenital 
heart disease. 143,150,182.235.255 mortahty from RSV is low, approximately 1-3% 
of hospital admissions die, mostly those with an underlying illness.
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Z2.Z1 Further lung disease
RSV has been imphcated in the development of chronic lung disease in 
subsequent years. Children with bronchiohtis have a higher incidence of further 
wheezing. 145.164.202.204.225.227.263,264 Recurrent respiratory problems have been noted 
in up to half of the children, but seem to diminish as children become older. The 
role of atopy in this sequence of events is unclear, some studies show an 
increased risk of further wheezing in children of atopic parents, whilst other 
studies have failed to do so. ^
n
2.2.3 Treatment
Treatment of RSV infection is largely supportive, aimed at mechanically clearing 
secretions obstructing the airways and maintaining nutritional and fluid status 
and oxygenation. Children who are hypoxaemic receive supplemental 
oxygen. As the main abnormahty in the affected lungs is a mismatch of 
ventilation and perfusion, relatively low concentrations of inspired oxygen are 
usually sufficient. This can be achieved with nasal prongs or nasal cannulae 
and low oxygen flow rates. Bronchodilators play a limited role in the 
treatment of RSV bronchiohtis. *^-^ 49.243.256 qtgy appear to be least useful in 
younger children. Some authorities recommend a trial of bronchodilator therapy 
and to continue with this treatment if there is clinical improvement after the 
apphcation. Steroids do not appear to be useful. Specific antiviral 
treatment with ribavirin may be beneficial in high risk children, but its cost- 
benefit ratio is low. 12.15/51.165.275 Secondary bacterial infections are uncommon, 
and children who received antibiotics had a higher rate of subsequent bacterial
13
infection. °^2.i4o,244 Therefore, routine antibiotic treatment of children with RSV 
infection is not recommended in developed countries.
2.2.4 Prevention
Prevention of RSV infection through vaccination has been hampered by a 
disastrous experience with a formalin inactivated vaccine in the 1960s which 
enhanced disease in vaccinated children and led to increased morbidity and also 
mortality, pruther efforts to develop a vaccine were aimed first at
understanding the mechanism of immune enhancement, but even today this is not 
completely understood. Development of a live attenuated vaccine was
thus considered a safer approach, but the vaccine candidates were either over­
attenuated and did not result in protection, or still caused lower respiratory 
infection. 2536.159.198.271,272 Mother ^proach has been the development of 
vaccines based on purified subunits of the virus such as the F protein or a 
chimeric FG protein. 22.177.200.220 There are some promising candidates, but 
currently, no vaccine is available for use in children.
Immunoglobulin with a high titre of anti-RSV antibody is effective at preventing 
severe RSV infection in children at high risk but its cost prevents more 
widespread use.
2.3 RSV in the developing world
2.3.1 Importance of RSV compared to other respiratory viruses
Earlier studies on the role of RSV in the aetiology of ARI used serology and/or 
viral culture. Immunofluorescence became available from the early 1980s 
onwards, and almost doubled the number of RSV positive cases.
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Z3.1.1 Community Studies
Several longitudinal community studies of children have identified viruses as the 
cause of 11%^^ to 36% of episodes of ARI. Five studies were performed 
without the use of immunofluorescence, *2,138.166.196339 Gve with
immunofluorescence. 25,119.238347350 ^q^gfeas the overall isolation rate of viruses 
remained similar (average 21% versus 23%), the percentage of RSV 
identifications doubled firom 23% to 44% (range 6%- 73%) in the studies that 
used immunofluorescence. As the overall isolation rate for viruses remained the 
same, viruses other than RSV were reported less fi-equently in studies which 
employed immunofluorescence. One stucfy did not identify RSV activily over a 
period of 29 months despite ^parently adequate methodology including antigen 
detection, immunofluorescence, and viral culture.
Table 2; Aetiology of ALRI in eommunity-bascd studies in developing eountries
Country &  study year method number number % virus RSV FTV Influenza Adeno 
reference studied virus positive (percentage of positive viral
positive_________________ identifications)________
Brazil ^38 1987-89 IF&
culture
50 15 30% 73% 7% 13% 0%
Uruguay 1985-87 culture & 
IF
858 131 15% 68% 8% 5% 8%
Philippines
247
1985-87 IF&
culture
311 106 34% 38% 15% 7% 10%
Thailand 250 1986-87 IF&
culture
674 109 16% 32% 34% 13% 15%
Otuxibia ^ 5 1988-89 culture, IF 
&
serology
491 55 11% 7% 25% 25% 33%
Panama 166 1963-64 serology 
& culture
150 54 36% 43% 46% 11%
Brazü239 1980 culture 371 76 20% 3% 7% 11% 29%
Colombia 32 1986-88 culture & 
serology
340 108 32% 62% 22% 9% 5%
India, Bengal 
138
1964-66 culture 4171 483 12% 2% 11% 33%
India, Bengal 
196
1966-67 culture 1716 224 13% 5% 8% 3% 54%
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2.3.1.2 Hospital in- and outpatient studies:
In studies performed in hospital outpatient departments or on patients admitted to 
hospital wards, a virus was found in 9% to 64% of cases of ARI (average
41%). RSV was found in 4% to 96% of cases with a proven viral aetiology
(average 39%). RSV was the leading cause of viral ARI, followed by influenza 
viruses, parainfluenza viruses and adenovirus.
Studies based on culture and /or serology only, which were all undertaken before 
the early 1980s, 30-55.70,123,129,193,211.222,229.232.241,274 on average a virus in 28%
of cases. RSV accounted for an average of 32% (range 6-72%) of the samples 
positive for viruses. Studies which used immunofluorescence before 1985 did 
not change these proportions considerably: a viral aetiology was found in 56% of 
cases, with identification of RSV in 24% of culture positive cases (range 11- 
33%). «2,109.199.207.217.253 pj-gm 1985 onwucds, immunofluorescence was used either
alone or in combination with serology or culture in 18 studies fi*oin developing 
countries. m2.so.76.77.82.ii8.i2o.i24.i63.i84.205.206.23<^238.248.262 QveruU vfral ætiology rate
did not change much fi*om that found in earher studies, with 33% of cases being 
attributed to a virus. However, RSV was imphcated in 65% (range 27 - 96%) of 
the samples positive for a virus. Thus RSV was, on average, responsible for 
17% of acute respiratory infections in children admitted to hospital in the 
developing countries where the studies were carried out.
Measles played a major role in some earher studies on ARI done in Colombia, 
the Phihppines, Papua New Guinea and Kenya. However, by the mid 
1980's, measles virus was no longer a significant cause of paediatric ARI in the 
studies reported, probably as a result of higher levels of immunisation.
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Table 3: Aetiology of ALRI in hospital-based studies in developing countries
Coimtry & study method number number % virus RSV n v Influenza Adeno
reference year studied virus positive (percentage of positive viral
positive identifications)
Colombia 184 1985-86 IF 60 20 33% 75% 15% 5% 5%
Argentina 262 1984-87 culture & 
IF
1002 304 30% 60% 7% 5% 9%
Brazil 238 1987-89 culture & 
IF
657 272 41% 96% 0% 3% 0%
Uruguay H8 1987-88 culture & 
IF
204 74 36% 82% 7% 1% 4%
India 50 1985-87 culture & 
IF
328 86 26% 76% 15% 1% 5%
India 124 1985-87 culture & 
IF
809 342 42% 48% 27% 9% 9%
India 1^3 1987 IF 230 51 22% 27% 31% 18% 24%
Philippines 248 1984-86 culture, 
IF& 
serology
537 163 30% 40% 17% 9% 13%
Philippines 42 1990-92 culture & 
IF
322 85 26% 69% 4% 5% 22%
Hong Kong 237 1985-88 culture & 
IF
681 272 40% 86%
Thailand 205 1986-87 culture, 
IF& 
serology
738 330 45% 43% 25% 14% 14%
Thailand 236 1988-89 IF 226 43 19% 93% 2% 2% 2%
Bangladesh 120 1986-88 culture & 
IF
601 127 21% 81% 4% 15% 4%
Bangladesh 206 1986-88 culture & 
IF
401 92 23% 63% 5% 16% 0%
Pakistan 82 1986-88 culture & 
IF
1492 553 37% 89% 2% 4% 5%
Gambia 27 1986-88 culture, 
IF& 
serology
74 25 34% 36% 8% 12% 28%
Gambia 76 1987-88 culture, 
IF& 
serology
90 42 47% 76% 7% 2% 10%
Gambia, well 1990-92 culture & 119 48 40% 31% 13% 19% 48%
nourished 1 IF
Gambia, 1990-92 culture & 158 55 35% 16% 18% 18% 49%
malnourished 1 IF
Madagascar 207 1983 IF 80 43 54% 23% 37% 30% 19%
Kenya 109,253 1981-82 culture & 
IF
835 451 54% 22% 4% 2% 4%
Phihppiuoa 217 1984 vulture, 
IF& 
serology
308 198 64% 11% 14% 34% , 6%
Singapore ^7 1976-84 culture, 
IF& 
serology
NA 2232 33% 13% 43% 6%
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Table 3 et.
Country & 
«fer^ce
South Afiica 
Uganda
study mefliod number number % virus RSV
year studied virus positive (P
positive
31%1983-85 culture & 886 444 50%
IF
12%1964-66 culture & 519 74 14%
serology
60% 6%1972-73 culture & 155 93
serology
42%1977 culture & 1229 250 20%
serology
72%1983 culture & 340 29 9%
sCTology
27%1978-81 culture & 62 15 24%
serology
28% 30%1977-79 culture & 1399 386
serology
50%1979-82? culture 180 52 29%
1981-83 culture & 369 148 40% 32%
serology
17% 6%1981-82 culture 184 32
1986-87 culture 596 268 45% 45%
1966-72 culture & 3139 836 27% 23%
serology
38%1972-73 serology 
& culture
662 180 27%
FIV Influenza Adeno
199
Jamaica 
Colombia ^ 0 
Colombia 30 
Panam a 211
P£q)uaNewQi 
222
Singapore
~  %  ~  ■»
== : :  5  5  E li
15% 5% 24%
20% 23% 22%
16% 24% 12%
11% 7% 34%
21%
7% 13% 33%
16% 32% 15%
32% 3% 15%
2.3.2 Epidemiology 
ZS.ZJ Age distribution
Few comimmily based studies have repotted the age distribution of children with 
RSV infection. *2.116.166.196.238.239 Qniy one study used immunofluorescence and 
documented only 11 cases with RSV, The study with the largest number of RSV 
cases foUowed a cohort of children in Colombia from birth to 17 months of 
age.“  Forty percent of RSV cases were found in the first 6 months of life, and 
46% in the second half year. Overall, there is insufficient information on the age 
distribution of children affected by RSV in the community.
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In hospital based in- or outpatient studies, the proportion of children aged 
between birth and 5 months of age with RSV infection varied between 9% 
and 87%. Taking only studies which included immunofluorescence or antigen 
detection, and which reported on children up to at least 5 years of age,
2/19,67,82,109,120,238,248 average 39% (range 20-62%) were under 6 months of age.
On average, children aged between 6 and 11 months of age comprised 24% of 
cases (range from 14-38%). Thus, on average, 63% of children were under 1 
year of age. Three additional studies which did not differentiate in the age group 
under 1 years of age found 62% of children und^ one year of age. On
average, 20% (range 13-29%) of the children were between 1 and 2 years of 
age.
Z3,2,2 Incidence rates of RSV-ALRI
Few studies attempted to quantify the incidence rates of RSV-ALRI. *°'*2,57,io8.238 
The reported incidence rates vaiy between 10/1000 children under 1 year of hfe 
for hospitalisation with RSV-ALRI in southern Israel to 198/1000 child years 
for the age group between birth and 18 months in a community based study from 
Colombia,^^
2.3.2,3 Sex distribution
Several studies have reported on the sex distribution of the patients. 
2,54,69,76.115.121,122,131.185.196.207.236,238,251 Twclve O U t of 14 S t u d i c S  f o u n d  a malc
predominance; on average 60% of infected children were male (range 43-88%).
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This male preponderance corresponds to the generally higher incidence of ARI 
of any aetiology in boys.
Z3.Z4 SeasonaUty
In most pubhshed studies, RSV has been a highly seasonal infection. RSV 
outbreaks in areas with temperate or Mediterranean climates in the southern 
hemisphere ^pear mainly during the cold months, as is the case in Western 
Europe and North America,"'^^^ This temperature dependent pattern appears to 
be independent of the rainfall pattern, as winter months have high rainfall in 
places such as Santiago, Chile, but low rainfall in places such as Johannesburg 
in South Africa (Figures 3 and 4). In desert climates such as Kuwait or 
Saudi Arabia, cases are seen also in the cold months.
In areas with tropical or sub tropical climates and seasonal rainfall, RSV 
outbreaks are associated frequently with the rainy season, and not with the colder 
season (Figures 5-9). The peak of RSV transmission is usually 1 to 2 months 
after the onset of the rains.
In countries close to the equator with perennial high rainfall, such as Singapore, 
Colombia, or islands such as Hawaii, the situation is less clear cut.
These countries have a distinct pattern of RSV transmission, with most cases 
appearing in one half of the year, but not in the other. But neither temperature 
nor rainfall appear to be the main determinant of the timing of these outbreaks. 
Studies from the north of the Indian subcontinent have shown contradictory 
patterns: Islamabad in Pakistan and Chandigarh in India have similar climates, 
and are only 500 km ^art, but they show different seasonahty patterns.
Outbreaks in Pakistan were reported to be mainly in the cold season, whereas
2 0
an outbreak described in Chandigarh was associated with the rainy season.  ^The 
situation is similar with regard to Calcutta in West Bengal and Dhaka in 
Bangladesh: outbreaks in Calcutta were reported mainly in the rainy season, 
116,138,196 ^jiQ-eas most of the cases from Bangladesh appeared in the drier, colder 
season.
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Figures of seasonality of RSV disease
Each graph depicts the mean monthly rainfall, the mean monthly maximum and 
the mean monthly minimum temperature as lines, and series of cases as bars with 
different hatches. The meteorological data were retrieved from the US National 
Climatic Data Center.
^m in im um  temp, ^m ax im um  temp, - e - average rainfall
■series/year1 a  series/year 2 a  series/year 3
EE series/year 4 a  series/year 5 i i  series/year 6
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Figure 3: Chile 1988-1989; Pakistan 1986-1988; India 1968. 
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Figure 4: Kuwait 1993-1994; South Africa 1966-1972; Saudi Arabia 
1991-1992.
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Figures: India 1964-1966;*"*' Bangladesh 1986-1988;*'" China 1978-1979."" 
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Figure 6: Hong Kong 1985-1986; Hawaii 1987-1989; Philippines 1984 
1985-1986/^
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Figure 7: Thailand 1968, 1986-1987, 1986-1987, 1988-1989; “  India
1985-1987; Trinidad 1964-1966. ™
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Figure 8. Panama 1983; Papua New Guinea 1983-85; Colombia 1977- 
1979. "°
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Figure 9: Singapore 1977-1979, 1980, 1989-1995; Kenya 1981-1982.
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2.3.3 Clinical features
2.3.3.1 Bacterial co-infections
Twelve studies looked for concurrent bacterial infections in cases of RSV 
infection. 1-2.50.76,82,115,118,124,206,222,248,253 isolation rate of bacteria varied
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between 2% and 50%. Most studies were very small, involving less than 
one hundred patients with RSV infection. A study from the Gambia, where the 
bacterial co-infection rate was 22%, included serology as well as culture as an 
indicator of bacterial infection. The only large study with a high bacterial 
isolation rate was that conducted in Pakistan in which bacteria were found in 
31% of all cases of RSV infection. In most studies, S. pneumoniae was the most 
frequently isolated organism, followed by H. influenzae.
2.3.3.2 Main utrition
Two studies from Africa report the influence of malnutrition on the prevalence 
of RSV. In a study from the Gambia, ’ where malnourished and well-nourished 
children with pneumonia were investigated concurrently, RSV was found in 13% 
of well nourished children with ARI, but in only 6% of malnourished children 
investigated. In a study from Nigeria, RSV was found in 16% of 
malnourished children with ARI, but in 55% of well nourished controls. In 
Papua New Guinea, Philipps et al did not find any association between RSV 
infection and malnutrition. These observations suggest that malnutrition is less 
of a risk factor for the development of severe RSV infection than for respiratory 
infections of other aetiologies.
2.3.3.3 Mortality
Fifteen studies 2 . 18,30 ,32 ,4 3 ,50 ,57 ,69 ,115 ,118,122, 185,217 ,237,251 case fatality for RSV
infection; this ranged from 0% to 6%. The majority of the hospital-based studies 
(8 of 14) did not report any deaths. A study from Argentina, which 
investigated 31 deaths from ARI, found RSV in 4 children; 2 of whom were
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preterm, and one of whom had a combination of RSV, adenovirus and 
Streptococcus viridans infection. In 4 out of 11 cases in whom no pathogen 
could be identified, a clinical diagnosis of bronchiolitis was made. On analysis 
of all studies reporting deaths, an association with a bacterial pathogen was made 
in 3 of the 18 reported RSV deaths (16%); two with Staphylococcus aureus, 
and the already mentioned streptococcal infection. Six children (33%) had 
additional risk factors: 2 were preterm babies, one had a low birth weight, 
one had a ventricular septal defect, and two had neurological disease.
Two studies from the south Pacific, which report cases of bronchiolitis without 
virological diagnosis, reported a case fatality rate of 2% and 11%, 
respectively. A study from India found a case fatality rate of 8.3% for clinical 
bronchiolitis, without determining the aetiology. Studies from Bangladesh 
and the Philippines report the case fatality rate of viral ARI to be much lower 
than bacterial ARI, 3% versus 7%, without specifying RSV explicitly.
The impact of RSV on mortality in the community cannot be assessed from the 
published literature.
2.3.3.4 Further wheezing
In developed countries, there is debate about whether RSV triggers further 
episodes of wheezing. There is only one published study from a developing 
country, Qa t a r ,wh i ch  examines this issue. It found that 44% of children with 
RSV bronchiolitis had further episodes of wheezing over the next two years, in 
comparison to only 13% of controls.
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2.3.4 Management
WHO has published guidelines for the treatment of acute lower respiratory tract 
infection in small hospitals and outpatient facilities. As an aetiological 
diagnosis is normally not possible in these settings, these are meant mainly to 
reduce mortality from bacterial infection through appropriate use of antibiotics. 
Further guidelines specify indications and practicalities of oxygen delivery 
which may be particularly important in children with RSV infection.
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2.4 RSV infection in The Gambia
Five of the previous studies on the aetiology of ALRI in Gambian children 
referred to in the introduction included virological studies. Table 4 summarises 
all aetiological ARI studies done in The Gambia to date. RSV was identified as 
the most important viral pathogen.
Since 1988, detailed records have been kept in the Royal Victoria Hospital in 
Banjul by the paediatrician in charge (and unpublished). This has made it 
possible to extract the monthly number of cases with a diagnosis of bronchiolitis. 
Figure 10 coiTelates clinical cases of bronchiolitis with periods during which 
RSV was isolated in the different studies.
Figure 10: Cases of clinical bronchiolitis, RSV isolations, and periods 
during which virological studies were undertaken (indicated by solid bar on 
top).
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No clear pattern of seasonality was discernible. One large outbreak of RSV 
occurred in the early dry season, the other in the wet season. Outbreaks were 
separated by 2 % years of irregular cases of bronchiolitis, but no virology was 
done during this period. RSV was not isolated, and serological evidence for 
infection found in only 4 cases during one entire year in a community study in 
Basse in Upper River Division. These confusing epidemiological data 
established the need for a more detailed and comprehensive study.
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Chapter 3. Materials and Methods
3.1 The Gambia
3.1.1 Geography
The Gambia is a small country on the west coast of Africa approximately 13° 
north of the equator. The country follows the river from which it derives its 
name for a distance of about 350 km inland from the sea. The maximal width is 
at the coast where it is 48 km across, but it narrows further inland to about 21 
km. The total area of The Gambia is 10367 km .^ Except for the coast line, the 
country is totally surrounded by Senegal. The land is generally flat, consisting 
of a sandstone plateau through which the river has carved its course. The river is 
bounded by plains which are saline in the lower reaches and therefore covered by 
mangroves and unsuitable for faiming. Further upriver, the river plains are 
flooded in the rainy season and used for rice farming.
Administratively, The Gambia is divided into 5 Divisions and 2 Municipal 
Areas. The two municipal areas are Banjul and Kanifing, each including the 
periurban areas around the coast. The divisions (seat of divisional 
administration) are Western Division (Brikama), Lower River Division (Mansa 
Konko), Central River Division (Janjangbureh), Upper River Division (Basse), 
and North Bank Division (Kerewan). The two municipal areas. Western 
Division and the western part of North Bank Division form the Western Region, 
the geographic area of this study.
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Figure 11: Map of The Gambia indicating the study area and the three 
main study hospitals, the Royal Victoria Hospital in Banjul, the MRC 
hospital in Fajar a, and the WEC Mission hospital in Sibanor.
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3.1.2 Climate
The climate of the Gambia is tropical with two distinct seasons: a dry season 
from November to June, and a wet season from June to October. The mean 
monthly figures for rain fall and temperature, as measured in Yundum at the 
coast, are shown in Figure 12.
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Figure 12: Mean monthly rain fall and maximum and minimum 
temperatures as measured at Yundum airport, Western Gambia.
rain fall (mm)temperature
40 400
30 300
20020
100
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
month
^minimum temp, -«-maximum temp, maverage rainfall
Note: The values are averaged for the years from 1990 to 1995.
The maximum daily temperature at the coast is relatively stable around the year. 
The average minimum temperature rises from minimal values in December of 
16° to 25° in August. Further away from the coast, maximum temperatures rise 
above 40° in the middle of the dry season.
The climate has become progressively drier over the last 50 years, the average 
annual rainfall has decreased from around 1400 mm per year in 1950 to around 
700 mm per year more recently. This trend is shown in Figure 13.
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Figure 13: Annual rainfall as measured at Yundum between 1951 an 1995
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3.1.3 Population
The population of the Gambia rose above 1 million for the first time in the 1993 
census. The highest concentration of the population is in the periurban areas 
of Banjul, Serekunda, and Brikama. About half of the population live in the 
Western Region. The annual growth rate of the population as calculated from 
the 1993 census is 4.2 %, part of which is a result of immigration rather than 
through births.
The main ethic groups in The Gambia are Mandinka, Wolof, Jola, Tula and 
Serahule. The vast majority of Gambians are Muslim.
3.1.3.1 Childhood population in the Western Region
The following table gives details of the population under 7 years of age provided 
by the 1993 census.
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Table 5; Population in early childhood by district in the Western Region of the 
Gambia, as reported in the 1993 census.
age group (years) < 1 1 2 3 4 5 6
Banjul 981 779 1008 1021 1025 956 882
Kanifing 6094 5287 6695 7205 6700 6302 6061
Kombo North 2637 2156 2810 3040 2874 2822 2656
Kombo South 1256 1080 1503 1639 1469 1547 1381
Kombo Central 1641 1487 1871 2047 1961 1844 1826
Kombo East 604 578 770 798 792 770 803
Foni Brefet 248 205 295 316 293 359 316
Foni Bintang 317 275 402 455 499 459 472
Foni Kansala 170 199 245 323 307 318 309
Foni Bondali 110 106 148 171 181 172 200
Foni Jarrol 129 125 159 196 203 217 189
Western Division 7112 6211 8203 8985 8579 8508 8152
Lower Niumi 1047 857 1269 1422 1329 1368 1239
Upper Niumi 688 545 855 893 884 840 856
Jokadu 452 397 594 710 679 601 657
North Bank West 2187 1799 2718 3025 2892 2809 2752
Total Western Region 16374 14076 18624 20236 19196 18575 17847
In this data set, the number of children in the lower age categories is lower than 
in higher age categories, which does not accord with expectation. Younger 
children must have been under-reported, a common feature in censuses in 
developing countries (A. Hill, personal communication). Computer programmes 
have been developed to adjust mis-reporting between age categories and to create 
a smooth pyramidal age distribution keeping the total number of persons 
reported in the census constant. Figure 14 shows the raw data for children in the 
Western Region, and after adjustment by the Arriaga method. As this 
method does not adjust for unden eporting, a second line is depicted which uses 
the adjustment and adds another 15% for underreporting to the number of 
children.
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Figure 14: Number of children in yearly age groups in the Western Region 
of the Gambia. Depicted are the raw data, the data adjusted by the Arriaga 
method, and after a further adjustment of 15%.
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3.1.4 Health system
The Ministry of Health, Social Welfare, and Women’s Affairs is responsible for 
health care in the country. For each division, health care is co-ordinated by a 
Divisional Health Team. The lowest level of health care is provided by Village 
Health Workers and Traditional Birth Attendants. These are generally illiterate, 
but have been trained in courses of 6-8 weeks duration to treat minor illness and 
refer more severe cases to a health centre. They are supervised by community 
health nurses. Minor health centres are based at bigger villages or small towns. 
These are manned by nurses, nurse midwifes and public health inspectors. They 
are the first point of referral, provide preventive services such as vaccination and 
antenatal care, curative services and deliveries. They generally have a small 
number of beds for inpatient care, but are not encouraged to retain patients with
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more severe conditions such as severe pneumonia, meningitis or cerebral 
malaria. Major health centres generally have a doctor in charge, a larger number 
of beds for inpatient care and are able to deal with the more severe conditions 
mentioned above. In the Western Region, they do not have facilities for major 
operations or operative deliveries. The next level of referral are two hospitals, 
one in Bansang in Central River Division, and the Royal Victoria Hospital in 
Banjul, the only paediatric referral hospital in the country.
Outside the Government sector, health facilities aie mn by private practitioners 
mainly in the periurban areas, and by non-govemmental organisations. The 
MRC maintains a outpatient clinic and 40 bedded hospital caring for medical and 
paediatric conditions. In Sibanor, a Protestant mission society (WEC) runs a 
major health centre with 38 inpatient beds.
3.2 Study methods
3.2.1 Clinical spectrum and epidemiology
3.2.1.1 Patients
Surveillance for RSV disease was undertaken in three hospitals in the Western 
Region of the Gambia: the Royal Victoria Hospital (RVH) in Banjul on the coast, 
the MRC Hospital in Fajara, approximately 15 km from Banjul, and Sibanor 
Mission Hospital 80 km inland. The RVH is the paediatric refeiTal hospital for the 
entire western half of The Gambia. The MRC hospital seiwes a mainly periurban 
population, whereas Sibanor serves a mainly rural population. Surveillance 
started at RVH and MRC in October 1993, in Sibanor in Januaiy 1994, and ended 
for the purpose of this thesis in December 1996. Children admitted to these
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hospitals were screened for RSV disease if they were less than 2 years of age and 
had any form of acute lower respiratory infection, if they received oxygen for any 
condition, or if one of the attending physicians specifically requested that the child 
should be screened. A considerable proportion of the children investigated were 
enrolled in a H. influenzae type b vaccine trial started in April 1993.
Outpatients were only enrolled if a study physician was present.
3.2.1.2 Sample collection
Nasopharyngeal aspirates were obtained from children in the study on each 
working day by a trained field worker. Samples from children admitted on a 
holiday were obtained on the next working day. A size 8 French suction catheter 
(Sheiwood Medical, Tullamore, Ireland) was introduced through one nostril into 
the nasopharynx. The catheter was connected to a mucus trap (Mucus Specimen 
Set, Bibby Sterilin Ltd., Stone, Staffs, UK) and suction was applied with a manual 
suction pump (Manuvac, Weinmann, Hamburg, Geimany). After a sufficient 
sample of mucus had been obtained, the catheter was washed through with 2 ml of 
sterile phosphate buffered saline and the specimen was transported to the 
laboratory on a cold pack in a cold box at 4 °C.
Children enrolled in the Hib conjugate vaccine trial and children admitted to 
MRC had blood cultures taken on admission. Blood cultures were not done 
routinely in Sibanor and RVH. Samples were collected by venepuncture into a 
syringe and inoculated into brain heart infusion and tiyptic soy broth 
immediately. Until transport to the main laboratory, blood culture bottles were 
stored in an incubator at 37°C. Further processing of blood cultures and 
isolation of organisms followed routine procedures as described previously. ^
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3.2.1.3 Data collection
After patients were identified as RSV positive, data were collected from the 
medical records. Children enrolled into the Hib vaccine trial and other formal 
studies in progress at that time had histoiy and physical examination 
documented in a standardised fashion and these data were used for the 
documentation of signs and symptoms (n=247). In other cases, clinical details 
were extracted retrospectively from admission or outpatients records. A data 
base was constmcted covering the histoiy and a range of vital and respiratory 
signs such as crepitations (crackles) and wheeze for each patient. If a 
complete physical examination was documented in the case notes, signs not 
mentioned specifically were considered absent. Outcome and duration of stay in 
hospital were noted from the patients records.
3.2.1.4 Calculation o f incidence rates
The number of hospital admissions in the three study hospitals was obtained 
from routine records in hospital discharge books. Census data were obtained 
from the Department of Statistics, Government of The Gambia, for towns and 
villages in the study area. The age pyramid was smoothed, but underreporting 
of young infants was not adjusted further. In this way, the number of children in 
yearly age groups was obtained for each of the 498 villages and settlements in 
the Western Region. Incidence rates were calculated for admissions with a 
discharge diagnosis of ALRI, RSV-ALRI, and RSV infection with hypoxaemia. 
As the study covered only part of 1993 and involved only 2 study hospitals in 
that year, incidence rates were calculated only for 1994 to 1996. One way 
transport fares by public transport to the study hospitals were obtained
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for each village, and the transport cost was used to stratify and adjust incidence 
rates by distance (Figure 15). For the unadjusted incidence rates, villages were 
grouped by transport fare into 5 groups: 0-2 Dalasis, 3-5 Dalasis, 6-10 Dalasis, 
11-15 Dalasis, and above 15 Dalasis (10 Dalasis = 1 US$). The childhood 
population in each age category resident in villages falling into each transport cost 
group was summed up and used as the denominator for the summed number of 
cases originating from these villages. Details on the calculation of adjusted 
incidence rates by Poisson regression are given below in Chapter 3.2.6.2.
Figure 1 : Contour map of the western region of The Gambia showing the 
minimum transport fare (one way) to one of the study hospitals.
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3.2.2 Community studies
Children were identified in hospital as described above. As soon as an index 
case was confirmed, usually within a week of admission, a field worker visited 
the compound of the index child and obtained consent from the compound head 
for a visit by the field team. The compound is the usual unit of living in the 
Gambia, where mostly members of an extended family share a common central 
space and some social tasks such as cooking. The compound corresponds to an 
extended household. Children 5 years of age or below were examined for the 
presence of respiratory infections. If a respiratory infection (upper or lower) was 
diagnosed, a nasopharyngeal aspirate was obtained from the child and stored and 
transported to the lab on ice. A serum sample was obtained on the initial visit 
and on a final visit 6 weeks later. In between these two visits, the compound was 
visited by a field worker twice a week, and nasopharyngeal aspirate samples 
were obtained from any child who had developed a fresh respiratory tract 
infection. During the 1994 RSV-season, a neighbouring compound was 
investigated in the same manner as the compound of the index case.
3.2.3 Risk factors study
Cases were detected through surveillance for RSV disease as described above. 
Children were included as cases if they were admitted to hospital in 1993 or 1994, 
were under one year of age, had a mother or guardian who was willing to answer the 
risk factor questionnaire, and who lived within approximately 40 km from one of the 
three study hospitals in the Western Region of the Gambia. After a case had been 
identified, a field worker interviewed the mother about a range of potential social and 
environmental risk factors, using a standard questionnaire. During 1993, controls
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were enrolled from a follow-up cohort of the Gambian Hib vaccine trial. Eligible 
for selection as controls were children registered in the same health centre as the 
case, matched for date of birth within a week, but who were not admitted with an 
ALRI during the time of the RSV outbreak during which the case presented. From 
1994, the questionnaire was extended to cover additional more immediate risk 
factors such as feeding, the type of meals, exposure to smoke and animals, and 
details of children on the compound. Controls for cases from 1994 onwards were 
enrolled after the outbreak from amongst children living in the same village or 
suburb, matched for age, who were not admitted to hospital during the outbreak with 
an acute respiratory tract infection. A field worker was visiting the nearest 
compound, inquired about children meeting above conditions and whether the 
parents were willing to participate. If either of this was not the case, he continued 
until both conditions could be met. Controls were enrolled and parents interviewed 
in the early dry season, whereas cases were mostly enrolled in the rainy season.
Each case child was matched with at least one control child, but none with more than 
2 control children. The risk factors covered in the questionnaire are shown in Table 
6 .
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Table 6: Potential risk factors for severe RSV disease covered in the questionnaire.
Age
Occupation
Nationality 
Educational level
Carer during the day 
Number of siblings alive
Father *
Carriage of the child on the 
back while cooking *
About the mother
Alive/dead 
Ethnic group 
Smoking habits 
About the father 
Alive/dead 
Occupation 
About the family 
Residence with the mother 
Haemoptysis in family 
member *
Asthma 
Mother *
Cooking
Frequency of cooking by 
mother *
Place where the cooking is 
normally done?
Nutrition 
Breast fed *
Other food 
Rice *
Milk powder or tinned milk *
Vegetables *
Social environment 
Number of people living in 
same house
Children sleeping in the same 
room with the child 
Children <1, <3, <5 years 
living on the compound (boys 
and girls separate) *
About the compound 
Electricity 
Walls of house
Number of rooms in the house 
Animals on the compound 
Chicken *
Cat *
Health care
Antenatal clinic attendance Place of delivery
Nationality 
Education level
Ethnic group 
Smoking habits
Co-wives
Nimiber of siblings
Sibling *
Carriage of the child on the 
back while cooking when the 
child is sick *
Pap *
Fish or meat *
Cow’s milk * 
Eggs *
Children under 2 years living Adults sleeping in the same
in same house room with the child
Children sleeping in the Children <5 sleeping in
same bed same bed
Water source 
Roof of house 
Disposal of rubbish
Goats *
Dog *
Toilet
Mosquito net 
Sheep *
Distance to nearest health 
facility
Mode of travel to the health 
facility
Consultation when a child 
was last sick
questions asked in the extended questionnaire in year 2 of the study
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3.2.4 Follow-up cohort study
Children with RSV infection admitted to hospital were identified as described 
above. Children were eligible for inclusion in the follow up cohort if they were 
under one year of age, lived on the south bank of the Gambia river up to a 
distance of approximately 40 km away fi om Banjul, and if the parents agreed to 
participate. Children for the control cohorts were enrolled from the same village 
or suburb as the cases. Children in control cohort 1, matched for age with cases, 
were enrolled after the RSV season had ended and, as a condition for being 
eligible, had not been admitted to hospital with an ARl during the RSV outbreak. 
Children in control cohort 1 might therefore have been infected with RSV, but 
the course of infection was not severe enough to warrant admission. Children in 
control cohort 2 were from a neighbouring compound of the case, but were bom 
after the RSV outbreak. Children in control cohort 2 were therefore younger 
than cases and children in control cohort 1, but they were most unlikely to have 
been infected in early infancy with RSV. Enrolment was undertaken in early 
1994, and again in early 1995.
Families of controls were asked to bring their children to MRC for recruitment to 
ensure that they knew the way to the hospital. A sticker identifying children as 
study subjects was placed on their health card and their case notes. Mothers 
were asked to bring their children to MRC if they developed any clinical 
problem. A field worker was trained to identify study children at the morning 
outpatient clinic of each working day. After weekends, the inpatient ward was 
checked for study children admitted over the weekend. Children who presented 
to the outpatients or who were admitted were seen by a physician who was
49
unaware of their previous RSV status. Patient notes and health card, which 
might have contained references to the previous RSV infection were only made 
available to him after he had filled in the documentation sheet. A standard form 
containing symptoms and signs relating to the acute presentation was filled in on 
each attendance of a study child. Respiratory syndromes were defined as 
follows: pneumonia - lower respiratory tract infection with fast breathing and 
crepitations (crackles) on auscultation without wheezing; wheezing: ALRI with 
wheezing, comprising wheezy bronchitis and bronchiolitis; ALRI: pneumonia or 
wheezing. Children received medical care according to best medical practice in 
the Gambia, and were admitted for inpatient treatment if this was required. To 
ensure free access to the MRC hospital, the transport fare was refunded to the 
patient. If a patient had not come for clinical attendance for more than 6 months, 
a field worker visited the home to find out whether the study child was still alive, 
whether the child had been admitted to another hospital in the meantime, or 
whether the child had moved permanently out of the area. The study was closed 
for the purpose of this analysis on 31/12/96. In this way, child months at risk 
could be calculated between enrolment of the child and the end of the study or to 
the time a child had moved away permanently.
3.2.5 Laboratory methods
3.2,5.1 Immunofluorescence
After obtaining aliquots for viral culture, nasophaiyngeal aspirate specimens 
were homogenised and centrifuged at 350g for 10 minutes. The pellet was then 
washed in phosphate buffered saline, centrifuged and spread on a microscopy
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slide, fixed and stained with a monoclonal, fluorescent conjugated anti-RSV 
antibody (Dako Diagnostics Ltd., Ely, UK). Slides were read under a 
fluorescent microscope, and RSV infected cells were identified by their 
characteristic pattern of fluorescence. Positive controls were included with each 
batch. Cases were defined on the basis of IF microscopy only.
3.2.5.2 Viral culture, subtyping and sequencing
To obtain viral isolates, a limited number of positive samples were cultured. 
Samples positive on IF were sequentially inoculated into HEp-2 cells and 
observed for up to 14 days. If a cytopathic effect developed, RSV was 
confirmed by IF again, and, if positive, the sample was snap-frozen in liquid 
nitrogen and stored at -70°C. Up to 30 culture-positive isolates were obtained 
per season. The cultured isolates were transported in batches on dry ice to the 
UK, where the isolated virus was subtyped and selected isolates further 
sequenced (Dr. Pat Cane, University of Wai*wick, Coventry). The methods used 
for typing are based on RT-PCR. Briefly, isolates were grouped and further 
genotyped by restriction analysis of PCR products derived from parts of the 
nucleocapsid (N) and G genes, together with some nucleotide sequencing of the 
G gene. Nucleotides 857-1135 of the N gene were amplified and the PCR 
products digested with HindiW, Pst\, BglU, Haelll and Rsal. Nucleotides 1-584 
of the G gene of group A isolates and 153-817 of group B isolates were also 
amplified and these products digested with Alul, Taql, Mhol and Msel. 
Nucleotides 285-514 of selected group A isolates were sequenced by automatic 
sequencing of PCR products.
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3.2.5.3 Neutralisation assay
Serum samples were assayed for neutralising antibodies against RSV using a 
microneutralisation assay against RSV group A (Tracy strain) and B (strain 
18537). Briefly, heat inactivated sera were diluted serially in 96 well tissue 
culture plates starting at a 3 logs dilution. Equal volumes (50 pi) of RSV (+/- 
100 TCID50) were added to each well. Positive control wells contained media 
rather than serum and negative control wells contained media only. These 
mixtures were incubated at 35°C for 1 hour. After incubation, 100 pi of 
trypsinised Hep-2 cells (2-4 x lO'^  cells) in EMEM with 10% FBS were added to 
each well. The sealed plates were maintained at 35°C in a 5% CO2 atmosphere. 
Twenty four hours after the positive control wells showed 100% cytopathic 
effect (CPE), the cells in all wells were fixed with 10% formalin and stained 
with 1 % crystal violet. The neutralising antibody titre was defined as the final 
semm dilution at which a >50% reduction in CPE occurred. Reference sera were 
run with each batch for standardisation and paired samples were run in the same 
batch.
3.2.6 Statistical methods
3.2.6.1 General
Frequencies were compared using Chi square test or Fisher's exact test, as 
appropriate. Normally distributed continuous variables were compared using 
Student's t-test while those which were not normally distributed were compai'ed 
using the Wilcoxon rank sum test. Analyses were performed using SPSS for 
Windows, Stata, and Epilnfo software packages.
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3.2.6.2 Clinical study and epidemiology
When applicable, variables were adjusted for age before comparison. Multiple 
logistic regression was used to identify variables correlated with a need for 
oxygen.
For the estimation of adjusted incidence rates of ALRI, RSV infection, and 
hypoxaemic RSV infection, for each disease category, a Poisson regression 
model was developed for the incidence of hospital admission in each settlement 
including the factors age group, sex, settlement population size, and settlement 
category (urban or rural according to the 1993 Census). In order to incorporate 
differences in access to the three hospitals into the model, the cost of travel to the 
nearest hospital (one way transport fares by the usual public transport - bus, boat, 
or taxi) was estimated for each village (see 3.2.1.4 and Figure 15).
3.2.6.3 Analysis o f risk factor study
Cases and controls were compared by matched analysis to produce estimates of 
the odds ratio for each variable. Conditional logistic regression was used to 
calculate odds ratios and 95% confidence intervals adjusted for the effects of 
other variables. All variables were candidates for inclusion in the regression 
models but variables were excluded if the odds ratio was not significantly 
different from 1 at the 10% level and if removing the variable from the model 
did not alter odds ratios for other variables. Exclusion of variables was done in 
two phases in order to reduce the effect of missing values on the number of 
matched sets included in the regressions. First, regressions were done separately 
for groups of related variables (e.g. nutritional variables, variables related to the 
family, the social environment - see table 6). Variables which remained in these
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models were candidates for inclusion in the overall final model. Lastly each 
variable was again tested for inclusion in the final model.
This analysis was done first using only variables in the original questionnaire, 
obtained during the whole study period. In a second step, the additional 
variables in the extended questionnaire, obtained only after the first year of the 
study, were also included in the analyses. This led to a second model which 
explored more variables but which, because of the smaller number of matched 
sets, had less power. The study had at least 80% power to detect an odds ratio of 2 
if the variable occurred with a frequency of 10% in the controls.
3.2.6.4 Follow-up cohort
FoiTTis for each attendance of a study child were entered into a data base. The 
code of group allocation was broken only after the data entry had been done. 
Primary endpoints were all episodes of acute lower respiratory tract infection, 
episodes of ALRI with wheezing, and the number of admissions due to ALRI.
A Poisson regression model was developed to determine the incidence rate ratio 
between case and control groups for each disease categoiy. This model included 
the factors age, sex, season (rainy or dry season), and care seeking behaviour. 
Care seeking behaviour was quantified by counting the number of attendances of 
each child at the clinic for conditions other than respiratory infections.
3.2.7 Ethical issues
The studies were approved by the Gambian Government/Medical Research 
Council Laboratories Ethical Committee. Verbal consent was obtained from the
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guardian for all procedures performed. All treatments given corresponded to the 
best medical care available in The Gambia.
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Chapter 4. RSV In The Gambia
4 .1 Epidemiology
4.1.1 Hospital based study
4.1.1.1 Overall description o f study patients
During the study period from October 1993 to December 1996, 574 children 
with RSV infection were identified, 254 at RVH, 210 at MRC and 110 at 
Sibanor Hospital. Five hundred and eleven children (89%) were admitted for 
inpatient treatment: 235 to RVH, 181 to MRC, and 95 to Sibanor Hospital. Most 
of the cases identified presented during outbreaks in the rainy season (July to 
November) of each year. The number of patients recmited per month is shown 
in Fig. 16.
Figure 16: Monthly number of RSV cases seen at the three study hospitals 
over the study period October 1993 to December 1996.
RSV-patients
80          80
60  1 .........-......................... -..................... -...............M g .......... 60
: I I k I :
ONDJ FMAMJ J A S O N D J  FMAMJ J A S O N D J  FMAMJ J ASOND  
I /93 I /94 I /95 I /96
month
Note: The rainy season is indicated by solid bars over the top
56
Five hundred and thirty-seven children came from the western region, their 
geographic origin is shown in Figure 17.
Figure 17: a. Geographic origin of RSV cases at RVH, MRC and Sibanor 
hospitals from 1993 to 1996 resident in the western region, b. Settlement 
size and distribution in the western region according to the 1993 census.
a.
50
10
1
b.
Population 
In 1993
^  40000
•  10000 
. 2000
Note: The number of cases from a village (in panel a) or the size of the village (in panel 
b) is indicated by the size of the dot.
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The median age of all children was 6 months, with a range of 9 days to 44 
months. The median age of children studied as outpatients (7 months) was httle 
different from those seen as inpatients (p=0.1). Age distributions during the 4 
outbreaks are shown in Fig. 18.
Figure 1 : Age distribution of the children seen during the four RSV 
outbreaks from 1993 to 1996..
patients
<1 2 4 6 8 10 12-14 18-20 24+
1 3 5 7 9 11 15-17 21-23
age (months)
Children were significantly younger in 1993 and 1996 than in the other 2 
outbreaks, the median age (interquartile range) being 3 months (2,6) in 1993, 7 
months (3,11) in 1994, 8 months (5,15) in 1995, and 5 months (2,11) in 1996 
(p<0.0001 comparing all outbreaks).
Fifty-six percent of the patients were boys. The sex distribution varied 
significantly with age: less than 6 months of age, 62% of patients were boys, 
whereas above 6 months of age, the sex distribution was more equal with 51%
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boys (p=0.008). Accordingly, the median age of boys was 5 months, while the 
median age of the girls was 7 months (p=0.045).
4.1.2 RSV sub typing
Sixty-seven RSV isolates were further subtyped: 45 were subgroup A and 22 
subgroup B. The proportion of infection caused by vims of subgroup A was 
90% in 1993, 25% in 1994, 75% in 1995, and 95% in 1996.
4.1.3 Incidence rates
The calculation of incidence rates was restricted to the full study years of 1994 to 
1996 During these three years, 3731 children under 2 years of age with a 
diagnosis of ALRI were admitted to one of the three study hospitals. Thirty- 
eight had no village of origin documented, 333 came from outside the western 
region, and 3 had no sex documented. The characteristics of the remaining 3357 
children by age group, sex, hospital and year aie shown in Table 7.
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Nasopharyngeal samples were obtained from 1643 children (49%). During that 
period, 375 children < 2 years of age from the study area were admitted with 
proven RSV infection. However, only 319 of these were accounted for with a 
diagnosis of ALRI in the discharge books of the hospitals and are therefore a 
subgroup of the above ALRI admissions (23 were not found in the books, 33 had 
another discharge diagnosis). Figure 19 shows the monthly number of ALRI 
admissions, the number of children sampled by nasopharyngeal aspirate, and the 
number of positives.
Figure 19: Monthly number of ALRI admissions, number of children 
sampled by nasopharyngeal aspirate, and the number positive for RSV in 
children < 2 years of age resident in the western region of The Gambia.
Number
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Note: Only RSV cases documented with a discharge diagnosis of ALRi in the hospital 
routine admission books are included in this graph.
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Fifty children with RSV-ALRI were hypoxaemic, characteristics of these 
children are included in Table 7.
The incidence rates for all ALRI, RSV-ALRI, and RSV infection with 
hypoxaemia varied with distance from the hospital as shown in Figure 20.
Figure 20: Incidence rate of all ALRI admissions, admission with RSV- 
ALRI, and hypoxaemic RSV infection in children under 1 year of age by 
transport fare (public transport) to hospital.
S
5
T3Ô
C
0.01
0.001
0.0001
4 8 13 171
all ARI 
RSV
hypoxaemic RSV
T ra n s p o r t  fare  (Dalasis)
Note: Transport fares are grouped into 0-2 Dalasis (1), 3-5 Dalasis (4), 6-10 Dalasis (8), 
11- 15 Dalasis (13), and above 15 Dalasis (17) (10 Dalasis = 1 US$).
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The incidence rate was highest in children nearest to hospital. For those whose 
transport fare to hospital was 2 Dalasis or under (10 Dalasis = 1 US$), the 
observed incidence rates for children under 1 year of age with ALRI was 10 per 
hundred children per year. For admission with RSV-ALRI, the incidence was 
0.9 per hundred children per year, and for hypoxaemic RSV-ALRI, 0.1.
Incidence rate for ALRI was significantly higher in males, in younger children, 
in mral settlements, and decreased as the size of settlement increased. For RSV- 
ALRI, incidence was also higher in males and in younger children, and 
decreased with increasing settlement size, but the difference between urban and 
rural settlements was not significant. In the case of hypoxaemic RSV-ALRI, 
incidence varied with age but was not associated significantly with sex, 
settlement size, settlement type, or travel cost to hospital. Incidence did not vary 
significantly year to year for any of the diseases. Incidence rate ratios ai e shown 
in table 8.
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The incidence of ALRI in children under 1 year of age, coiresponding to travel 
cost of 2 Dalasis or less, estimated from the regression model, was 11.4 (95%CI 
10.6,12.3) per hundred children per year for boys in urban areas, and 9.1 
(8.4,9.9) for girls, and in rural areas 16.1 (14.6,17.6) for boys and 12.8
(11.6,14.1) for girls. For RSV-ALRI, the incidence was 1.3 (1.1,1.6) per hundred 
children per year for boys, and 1.0 (0.8,1.3) for girls, in both urban and mral 
areas. For hypoxaemic RSV-ALRI, the corresponding estimates were 0.1 
(0.07,0.19) and 0.07 (0.04,0.13) for boys and girls respectively.
19.4% (319/1643) of ALRI cases who were sampled were positive for RSV, but 
only 49% of ALRI cases had nasopharyngeal aspirates taken. Thus the RSV 
incidence figures underestimate the tme incidence, which may be twice as high 
(2.6% for boys, 2% for girls).
4.1.4 Household study
During the 1993 and 1994 RSV seasons, 103 case- and 22 control compounds 
were visited. The mean number of children in the case and the control 
compounds were 5.2 (SD 3.5) and 5.1 (SD 3.0), respectively. Paired serum 
samples were obtained in 68 case compounds and 22 control compounds from 
237 case compound and 83 control compound children 5 years of age and below. 
The mean age of these children was 29 months (SD 17) for both the case- and 
the control compounds. Of the 320 children studied, 85 (27%) had either a rising 
antibody titre or vims detected by IF; 25% of the children in the case compounds 
and 31% of children in the control compounds. The rate of infection in the 
individual compounds ranged from 0% to 100%. Infection rates were lowest in
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the 2-3 years old (16%) and equally high in the 0-1 and 4-5 years olds (33%). 
Incidences of infection did not differ significantly between case and control 
compounds and between age groups.
4.1.5 Discussion
RSV disease has been studied in Gambian children during four rainy season 
outbreaks. During these outbreaks, RSV was a major cause of hospital 
admission. It was shown that distance to hospital influenced admission for ALRI 
overall and for RSV-ALRI overall. Comfortingly, and surprising, a significant 
decline of cases with distance from hospital was not found for RSV-ALRI cases 
with hypoxaemia. As the three study hospitals are the only ones in the western 
region that provide oxygen, this finding indicates that the referral system worked 
well for the most severe cases.
The incidence rate for ALRI admission to hospital in the first year of life and the 
villages nearest to the health facilities of around 10% is on the lower side of that 
reported in other studies 30,32,75,146,247,252^ but the children in our study represented 
only the more severe end of the spectrum of ALRI.
The incidence rate of RSV-ALRI observed is likely to be a gross underestimate. 
Only half the children with ALRI were sampled, and in those sampled we are 
likely to have missed an additional number of cases, as diagnosis with 
immunofluorescence alone has a limited sensitivity, and the transport of 
samples from distant health facilities further decreased the yield. Estimating 
from the excess of admissions with ALRI during the RSV season, we estimate 
the real incidence to be around 3% for admissions with RSV-ALRI during the 
first year of life. This is a similar incidence for RSV-ALRI to that reported from
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Alaskan Natives but higher than that reported in Bedouins from southern 
Israel We found a higher incidence rate in boys than in girls, an almost 
universal finding in ALRI. The difference in the observed incidences with 
distance might indicate, however, that part of this difference is due to better care 
seeking behaviour for boys. Incidence rates for ALRI were higher in rural 
settings, but for RSV-ALRI, the incidence rates were higher for urban areas. For 
both ALRI and RSV-ALRI, the incidence rates were lower in bigger villages.
As most of the smaller villages are poorer than the bigger ones, this might 
indicate the influence of the overall living standard on the incidence of ALRI, 
but to a lesser degree on severe RSV infection. A steady decline in the incidence 
rate ratio for the second year of life from 0.55 for all ALRI, to 0.32 for RSV- 
ALRI and 0.2 for hypoxaemic RSV infection was observed (Table 8), indicating 
that RSV plays less of a role in the second year of life than other pathogens, and 
that hypoxaemia becomes uncommon.
These outbreaks suggest a predilection of RSV for the wet season, as has been 
described from other tropical countries with seasonal rain fall. ‘^2,50,109,185,237,241 
Although only a limited number of viral isolates was subtyped, we observed 
some alternation between the predominant subgroups of virus. This alternating 
pattern, and the overall dominance of subgroup A, are similar to the situation 
described in temperate climates. ‘^ - 28 . 104, 112,210,246
Children in 1993 were significantly younger than those seen in the other years. 
This is likely to be due in part to the study design, as children who were enrolled 
in the Haemophilus vaccine trial were more likely to have been investigated as
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possible cases of RSV infection than other children, and in 1993, the vaccine 
trial had just started, so only young children had been enrolled in the trial. In 
addition, the study started in the middle of an outbreak, and, as noticed in the 
other three years, the mean age of children decreased as the outbreak progressed. 
A further possible explanation for the change in the age distribution observed 
might be limited cross immunity between viral subgroups. In general, the age 
distribution observed is consistent with that reported from other developing 
countries, where, on average, half the children in hospital based studies were 
reported to be less than 6 months of age. 49,54,66,67,76,193,238 majority of the 
children less than 6 months of age were boys, as described in developed 
countries, possibly because of smaller airways in boys.
In the compound study, we were able to demonstrate that, during outbreaks of 
RSV, the virus circulates widely in the community. Between a quarter and a 
third of children in the compounds investigated had evidence of recent infection. 
This figure is likely to be an underestimate, as we visited compounds only after 
an index case, usually a young infant, had been admitted to hospital. If the 
number of new cases in the compound follows a bell shaped distribution, we are 
likely to have visited the compound when the number of new cases was already 
declining. Thus it is possible that the true number of infected children on the 
compounds was double the number that we observed. In community based 
studies in industrialised countries, infection rates of between 69% and 98% 
have been observed in the first year of life, with little or no decline in the 
second year of life. Monto found a yearly infection rate in the age group of 5-
6 8
9 years olds of 19.7 %. In a family study, Hall reported an overall infection rate 
of 29% for infants, and of 63% within infected families.
In summary, we have shown that RSV was responsible for a considerable 
number of hospital admissions in small children in the Gambia, especially during 
the rainy season. It poses a considerable burden on the health system through a 
demand on hospital beds and oxygen. Thus, prevention of RSV infection by 
vaccination is likely to be cost effective.
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4.2 Clinical spectrum of RS V infection
4.2.1 Presenting complaints and physical signs
In 519 of the 574 (90%) children with RSV infection, clinical information was 
available to analyse presenting complaints and physical signs during presentation 
to hospital. The main presenting complaints were cough (87%), fever (84%), 
“chest pain” (25%), vomiting (22%), breathing difficulty (21%), diarrhoea 
( 10%), fast breathing (9%) and poor feeding (3%). The median duration of the 
main symptom was 3 days. Physical findings on examination were available 
from 472 inpatients and 47 outpatients, the main physical signs, and differences 
in signs between in- and outpatients, are presented in Table 9.
Table 9: Comparison of physical findings in inpatients and outpatients with 
RSV disease. (N=519, percents in brackets)
Sign Categories Inpatients
(n=472)
Outpatients
(n=47)
p-value
nasal flaring present 191 (40%) 22 (47%) 0.47
lower chest wall moderate or 241 (51%) 16 (34%) 0 03
indrawing severe
9(19%) 0.28grunting present 130 (28%)
crepitations present 379 (80%) 19 (40%) <0.0001
wheezing present 182 (39%) 35 (75%) <0.0001
rhonchi present 163 (35%) 30 (64%) 0.0001
wheezes or present 240 (47%) 40 (85%) 0.0001
rhonchi
respiratory rate mean (SD) 65.7(14.9) 55.6(11.2) <0.0001
temperature mean (SD) 38.1 (0.96) 38.1 (0.86) 0.6
Sa02 median 95 (92,98) 98 (96,99) <0.0001
(25%,75%)
0.22heart rate mean (SD) 157(18.4) 153 (18.9)
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Clinical examination of the chest was normal in 41 children (8%). Young 
children had a lower average temperature than older ones: the median 
(interquartile range) temperature of children less than 3 months was 37.6°C
(37.1,38.2), that of those between 3 and 5 months 38.1°C (37.6,38.7), and that of 
those aged 6 months to 23 months of age was 38.4°C (37.8,39.1). Median 
temperature dropped again for those 2 years of age and above to 37.6°C (37.1, 
38.0) (p<0.0001 for overall comparison between all groups).
Up to 6 months of age, RSV cases were above the mean weight of the NCHS 
standai'd, after 6 months of age, the weight for age dropped gradually against 
the NCHS standard (Fig. 21).
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Figure 21: a. Weight for age of children with RSV infection by age. b. 
Weight for age of presumably healthy children from several surveys in The 
Gambia
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then grouped together above. The box plot depicts the interquartile range as a box, and 
the median as a line in the box. The bars depict the maximum and minimum values.
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Presenting diagnoses were pneumonia in 74% of cases, bronchiolitis in 40%, and 
asthma in 0.8%. Ninety-seven percent of children had a diagnosis of pneumonia 
o r  bronchiolitis. Additional diagnoses were malaria (4.0%), congenital heart 
disease (1.6%), severe malnutrition (2.6%), and sickle cell disease (0.4%). 
Thirteen (2.4%) children had underlying conditions likely to increase the risk of 
severe RSV disease (8 congenital heart disease, 2 Down’s syndrome, 1 rickets, 1 
malformed lung, 1 hydrocephalus). The median duration of hospital stay was 3 
days, with a range from 1 to 28 days (interquartile range: 2,5 days). Thirteen 
children (2.4 %) died. Details of these children are presented in Table 10. All 
children who died received antibiotics, most of them chloramphenicol or 
ampicillin and gentamycin.
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4.2.2 Oxygen
Eighty of the 511 children admitted to hospital (16%) received oxygen because 
of hypoxaemia, defined as an arterial haemoglobin oxygen saturation below 
90%, or because this was warranted on clinical grounds in patients whose 
saturation was not documented. The median duration of stay of children who 
received oxygen was 5 days. The median age (interquartile range) of children 
who required oxygen was 4 months (1,8), compared with a median age of 6.5 
months (3,12) for children who did not require oxygen (p=0.002). Forty percent 
of admitted children younger than 1 month, and 24% of those between one and 
two months of age required oxygen. At the other end of the age spectrum, 19% 
of children older than 18 months required oxygen, whereas in those between 
these age groups, 12% required oxygen.
4.2.3 Predictors of hypoxaemia
In a multiple logistic regression model, factors associated with hypoxaemia were 
age, temperature and respiratory rate. Children were more likely to require 
oxygen if they were very young or older than 18 months, the risk was lowest for 
children of intermediate ages (see univariate analysis above). After adjusting for 
the influence of age (using age as a quadratic term), a drop in temperature (OR 
1.4, 95% Cl 1.03,1.88 for each degree of temperature) and increase in 
respiratoiy rate (OR 1.48, 95% Cl 1.25,1.76 for an increase in respiratory rate of 
10 breaths per minute) were significantly associated with hypoxaemia
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4.2.4 Concomitant bacterial infections
Blood cultures were obtained from 255 children. Nine cultures were positive, 
seven of which were blood cultures (2.7% of all blood cultures). Four isolates 
were S. pneumoniae, 2 H. influenzae type B, 2 S. aureus, and one Enterohacter 
agglomerans. All organisms were found in blood cultures, except for one H. 
influenzae which was isolated from a pleural effusion, and one S. aureus which 
was isolated from a lung aspirate. The mean temperature of the bacterial culture 
positive cases was significantly higher than the mean temperature of those 
children who were bacterial culture negative (39.2°C vs. 38.2°C, p= 0.01). No 
other physical findings were significantly different between bacterial culture 
positive and bacterial culture negative cases.
4.2.5 RSV subtyping
The duration of stay in hospital was significantly longer for children with 
subgroup B infection as opposed to subgroup A (median 5 days versus 3 days, 
p=0.02). No other clinical measurement differed significantly between the two 
RSV subgroups.
4.2.6 Discussion
The history of most children was very short. Presenting complaints are specific 
to the cultural setting; fever is the complaint mentioned by the mothers of almost 
all sick children in the Gambia, irrespective of temperature. Chest pain denotes 
any problem conceived as coming from the chest. In contrast to a study in India, 
rapid breathing or indrawing was rarely mentioned in The Gambia. 
Gastrointestinal symptoms were mentioned in about a quarter of the patients.
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The strongest predictors of admission were the presence of crepitations, higher 
respiratory rate and lower age, similar to findings from developed countries.
In contrast to a study from Australia, the risk of requiring oxygen increased 
with increasing respiratoiy rate. The higher frequency of wheezing seen in 
children studied in outpatient as opposed to those seen in hospital might in part 
be explained by the study design, i.e. children with wheezing were included in 
the outpatient study, whereas children with a mild respiratory disease not 
requiring admission would normally not have been investigated. A low 
prevalence of wheezing in children with proven RSV disease has been reported 
from developed countries previously. The age-dependency of temperature is 
noteworthy. Younger children rarely responded with an increased temperature, 
in line with findings from Israel, where only 40% of the children had a 
temperature above 38°C. In contrast, all the children with a positive blood 
culture had a temperature of 38.5 °C or above. Higher temperature being a 
predictor of positive blood cultures was previously found in another study in the 
Gambia. This might be a useful guideline to decide which children seen 
during RSV outbreaks require treatment with antibiotics. Current treatment 
algorithms for acute respiratory infections do not consider temperature.
The nutritional status of the study children was generally good; children less than 
6 months of age were heavier than the American standard. Although weight for 
age fell in older children in comparison with the NCHS standard, children with 
RSV infection did not differ from other Gambian children. This is in 
agreement with a study from Nigeria, where RSV was not found more frequently 
in malnourished children, and with a previous study from The Gambia, in
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which RSV was found significantly less frequently in malnourished than in well 
nourished children with pneumonia. '
Thirteen children died. Three of these deaths were probably unrelated to RSV 
infection, reducing the in hospital death rate to 2% . This relatively low case 
fatality rate is explained in part by the availability of oxygen in the hospital and 
by the existence of established guidelines for oxygen therapy. It is noteworthy 
that no deaths occurred in the first study year, when special efforts were made to 
identify hypoxaemic children for a concurrent study on methods of oxygen 
delivery. On the other hand, very few children with underlying heart or lung 
disease were found in the study population. Most of the study children were 
routinely treated with antibiotics, but no specific anti-viral agents are available in 
The Gambia.
The low rate of positive blood cultures obtained (2.7%) is in concordance with 
findings from developed countries, where bacterial superinfection in RSV 
infection is considered unusual, but contrasts with findings from Pakistan, 
where 31% of RSV infected children had a positive blood culture. A previous 
study in The Gambia, in which only very sick infants were included, found a 
bacterial organism in 7/32 (22%) of cases of RSV infection. However, in this 
early study, the diagnosis of a bacterial infection was based on serology as well 
as culture and may have overestimated frequency. Most other studies from 
developing countries report very small numbers of culture positive cases, the 
isolation rate varying between 2% and 10%. 118,124,248,253 predominant
organisms found in our study, S. pneumoniae and H. influenzae, were the same 
as those obtained in these other studies. As blood cultures are insensitive for the
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identification of bacterial causes of pneumonia, all these numbers are probably 
underestimates, but nevertheless the rate of bacterial infection appears to be low 
in Gambian children with RSV disease.
In summary, the clinical presentation of children with RSV infection is similar to 
that in developed countries. The frequency of underlying conditions is low, 
however, indicating that it is mainly otherwise normal children who develop 
severe RSV infection. Concomitant bacterial infections are uncommon. As the 
acute mortality observed in those children is not negligible, efforts at prevention 
and case management with oxygen are worthwhile.
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4.3 Risk factors for RSV infection leading to hospital admission: 
a case control study
Two hundred and seventy-seven cases were enrolled in the study (representing 79% 
of hospital admissions with RSV infection during that time, with another 4% coming 
from outside the study area), together with 364 controls. The extended questionnaire 
was completed for 172 cases and 222 controls. Fifty-five percent of the cases were 
boys, as were 50% of the controls. The median (interquartile range) age was 9 
months (5,14) for cases and 9 months (5,15) for controls.
The statistically significant results of the univariate analysis of the original 
questionnaire are shown in table 11, the results of the extended questionnaire are 
shown in table 12.
In the final regression model (Table 11) based on variables in the original 
questionnaire administered over two years, four main risk factors for severe RSV 
disease were identified; a larger number of people living in the house; having 
had a sibling who died; living in a house with a flush toilet rather than pit-1 atrine 
or no toilet; and belonging to a family with a non-Gambian, rather than a 
Gambian, father. There were also slight effects of father’s occupation and the 
type of child care, but these were of borderline significance.
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Parental smoking was equally common for cases and controls: 39% of the fathers of 
cases smoked, compared with 41% of fathers of controls. Mothers smoked 
infrequently (2% in both groups).
To examine the additional variables in the extended questionnaire, the second step of 
the analysis was restricted to the second year of the study (Table 12). Variables in 
the original questionnaire had similar unadjusted odds ratios in the second year and 
for both years combined, except for child care by the mother which was associated 
with increased risk in the combined data but with reduced risk in the second year.
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Figure 22 shows selected parameters and their odds ratios from Table 12 in 
graphic form
Figure 1: Adjusted odds ratios for statistically significant and other selected 
risk factors for severe RSV infection based on the extended questionnaire.
Child care by mother
Child carried during cookin
Flush toilet in house
Electricity in house
Water from tap
Father Gambian national
Mother cooks at least once dail
>2 other siblings
Had sibling(s) that died
Eating vegetabl
>1 older child on compound
0 .1  0 .2  0 .4  1 2 3 5 10
odds r a t i o
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There were more detailed questions in the extended questionnaire about numbers and 
age groups of children in the compound. Some of these new variables were more 
strongly associated with severe RSV disease than the variables in the original 
questionnaire. The adjusted odds ratios for those other variables were smaller and 
lost significance in this second analysis. Examining the contribution of numbers of 
children of different age groups on the compound, the strongest risk factor was a 
larger number of children in the 3-5 years age group (Table 12 and Figure 23). The 
sex of these children had no effect on risk either when numbers of boys and girls or 
when numbers of children of the same or different sex as the index case were 
considered.
Figure 23: Percentage of compounds with 2 or more children in the age groups 
under 1 year, aged 1 or 2 years, and aged 3 or 4 years resident on the 
compound.
% of compounds
< 1 year 1 & 2 years 
age group
m cases 
^  controls
3 & 4 years
The extended questionnaire included new questions on nutrition, asthma in the 
family, and exposure to cooking fumes. Eating vegetables was more common in
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controls than in cases (OR 0.18, 95%CI 0.07, 0.48), the difference was found to 
be more marked in older children (Figure 24).
Figure 24: Percentage of children eating vegetables by age category.
proportion of children (%]
12-14 18-20
15-17 21-23 24+
0602<01
110907050301
age (months)
■cases -^controls
Breast feeding was almost universal, 87% of cases and 89% of controls were 
breast fed (OR 0.64, p=0.3). Exposure to cooking fires was significantly more 
common in controls than in cases in the univariate analysis, the mothers of 
control children cooked more frequently than the mothers of cases (OR for 
cooking more than once daily after multivariate adjustment 0.32, 95%CI 0.15, 
0.7), but the odds ratios for the other two cooking-fume related variables (the 
child being carried on the back while cooking and carried on the back while 
cooking when sick) became non-significant after multivariate adjustment. 
Maternal asthma was a significant risk factor in the univariate analysis (OR 8, 
95% Cl: 1, 64, p=0.05), but due to the small number of affected mothers (n=9), 
this could not be analysed in the multiple regression analysis.
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4.3.1 Discussion
In line with other studies from developing and developed countries, crowding was 
the most important risk factor for admission to hospital with RSV infection found in 
our study; 117,143,250 people lived on the compounds of cases than of 
controls. In the final model, an increasing number of children in the household 
between the ages of 3 and 5 years was the strongest risk factor identified for 
admission to hospital with RSV infection. As these children are more mobile than 
their younger siblings, it is likely that they introduced the virus to the compound, and 
that more exposure leads to more severe disease as many of the control children are 
likely to have had mild infection. We did not document the number of children 
older than 5 years of age and of adults on the compound in detail, so we could not 
explore their influence on severe infection. In contrast, the number of younger 
children, and the number of children sharing a bed and a room was similar in both 
groups.
Exposure to cooking fire showed an inverse relation with RSV infection. This is 
surprising as studies from different developing countries have shown exposure to 
wood smoke and cooking fires to be a risk factor for ALRI overall, and for 
bacterial pneumonia in particular. As the association was consistent in several 
questions dealing with similar issues, it is unlikely to have been a chance event. It is 
possible that the relation found in other studies is due to bacterial infections, and that 
bacterial and viral infections behave differently. Interestingly, a study from Papua 
New Guinea found a similar inverse relation between obstructive airways disease in 
children and wood smoke exposure.  ^ Exposure to tobacco smoke was not related to 
RSV infection in this study. However, smoking mothers are rare in the Gambia.
In developed countries, breast feeding has been shown to be protective against severe 
RSV infection. most of the children in The Gambia are breast fed up to
18 months of age, it is not surprising that no protective effect of breast feeding could 
be shown. The only nutritional factor which was more commonly found in controls 
than in cases was eating vegetables. This was most pronounced in older children. 
This potentially interesting finding could be explained by the seasonal 
availability of vegetables. Garden vegetables are generally planted towards the 
end of the rainy season, and become available in the early dry season. As 
controls were enrolled on average 3 months later than cases, this association might 
be caused by the study design. It is possible, however, that part of the seasonality of 
RSV infection in the Gambia might be explained through the availability of 
vegetables rather than climatic factors. Similarly, the finding that more mothers of 
controls were looking after their children during the day in the second study year 
might be partially explained by seasonal differences of extradomestic work, which 
might leave the children in the care of another person. One problem of the study was 
the change of the selection procedure for the controls, which was considered 
necessary to include more acute parameters, but might have introduced bias into the 
study. It was therefore comforting to see that all variables had similar odds ratios in 
both years except the day care by the mother, for which we tried to offer an 
explanation above.
Genetic factors may play a protective or disease enhancing role. This could explain 
the finding that the father being non Gambian was more frequent in the cases. The 
observation that more siblings had died on the case compounds may point in the 
same direction of a genetic susceptibility to severe disease. However, other 
differences in life style between groups might explain this finding, for example
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mothers who had lost a child previously might be more likely to seek medical 
attention.
Socio-economic factors did not seem to play a major role in predisposing to severe 
RSV infection. The housing and environmental conditions in which cases and 
controls lived were similar, and the educational status of parents of cases and 
controls did not differ substantially. If socio-economic status played any role, lower 
social status seemed to be rather more protective. Fathers of controls were more 
frequently manual workers or policemen, and compounds of cases had more 
frequently tap water and flush toilets, the association with the latter was strong and 
independent of other factors in the first model. One possible explanation for this 
unexpected finding is that better hygiene predisposes to more severe RSV disease. 
Alternatively, the effect might be explained by differences in care seeking behaviour. 
Parents of lower socio-economic status might be less willing to present children to 
hospital even if they have disease of a severity which necessitates admission, or 
parents of higher status, and mothers who had previously lost a child, might more 
effectively push their child through the health system to gain admission. For either 
of these scenarios, children of higher social class would be over-represented in the 
case group.
Asthma was very uncommon in both cases and controls. However, a history of 
asthma was obtained significantly more frequently in mothers of cases. This might 
indicate a small role of atopy in developing severe RSV infection.
In summary, few important differences were found between cases and controls in 
social and environmental risk factors, despite the fact that the study had at least 80% 
power to detect an odds ratio of 2 if the variable occurred with a frequency of 10% in 
the controls. The risk factors found do not explain much of the attributable risk, such
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as maternal asthma, are not easily remediable, such as family size and exposure to 
older children, or considered advances in life style such as flush toilets or taps on the 
compound. Other factors which are considered to predispose to bacterial pneumonia 
had an inverse relation with severe RSV infection. Improvements in social and 
environmental conditions are likely to have little effect, but this requires further 
studies. For the control of RSV infection in developing countries similar to The 
Gambia, efforts should concentrate on prevention through vaccination and case 
management.
91
4.4 Sequelae: Cohort study of further respiratory illness
One hundred and five children with RSV infection were enrolled into a study of 
the long-teim sequelae of severe RSV infection, together with 105 age-matched 
control children bom at the same time as the cases and 102 children bom after 
the respective RSV outbreaks. The age at enrolment (interquartile range) was 8 
months (6,11) for cases, 8 months (7,11) for children in control group 1, and 2 
months (2,4) for children in control group 2. The number of children ever seen 
after enrolment either at the clinic or on a follow up visit by a field worker in the 
case and control groups were 90, 104, and 98, respectively; 76, 67 and 79 
respectively, attended MRC at least once for a medical problem. The median 
time of follow up (interquartile range) was 25 months (22,33) for cases, 25 
months (22,32) for control group 1, and 19 months (19,32) for control group 2; 
the total time of follow up was 2322 months for cases, 2560 months for control 
group 1 and 2304 months for control group 2. Cases were seen at MRC on 387 
occasions, children in control group 1 on 237 occasions, and children in control 
group 2 on 309 occasions. The median age (interquartile range) of children at the 
end of the follow up period was 40 (34,42), 39 (34,41) and 33.5 (23,36) months 
for case and control cohorts 1 and 2, respectively.
The main diagnoses on these occasions are shown in Table 13.
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Table 13; Diagnoses during hospital and outpatient attendances of the children in 
the follow-up cohort.
Diagnosis cases control 1 control 2
total number of attendances 
(outpatient and inpatient)
387 237 309
pneumonia 83 34 37
ALRI with wheezing 22 7 7
otitis media 16 4 11
gastro-enteritis 57 48 70
bloody diaiThoea 10 3 7
mouth infection 8 2 6
skin infection 57 36 46
malaria 39 23 33
Note; Multiple diagnoses could be made.
Children from the 3 groups were admitted to hospital for inpatient treatment on 
47, 33, and 40 occasions, respectively. Pneumonia was diagnosed on at least one 
occasion in 28 case children (31% of those ever seen), 12 (12%) children in 
control cohort 1, and 14 (14%) children in control cohort 2. Wheezing was 
diagnosed in 13 (14%), 2 (2%), and 5 (5%) children in the three cohorts , 
respectively. Most of the episodes of respiratory illness were seen during the 
months from July to December (Fig. 25).
Ten children had proven episodes of RSV infection: 4 in the case group, one in 
control group 1, and 5 in control group 2. One, 1, and 4 children in these gi'oups 
were admitted for inpatient care, respectively. Four of the episodes were in 
1994, and 6 in 1995.
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Figure 25: Number of children diagnosed as having pneumonia or wheezing 
in the follow up cohorts (ARI cases cohort), compared with the seasonality 
of RSV infection in the Western Region of The Gambia as determined by 
hospital surveillance (RSV cases).
ARI cases cohort RSV cases Western Reaion
M M J S N J M M J S N J M M J S N
A J A O D F A J A O D F A J A O D
I  /94 I  /95 1 /96 I
ARI 
RSV cases
Using Poisson regression to determine a model predicting pneumonia, wheezing, 
pneumonia or wheezing, and admission with pneumonia or wheezing, being a 
child in the case cohort, age, season, and care seeking behaviour were found to 
be significant predictors, after adjustment for the other variables, for pneumonia 
and pneumonia or wheezing, being a case, season and age for wheezing, and 
being a case, age and care seeking behaviour for being admitted with pneumonia 
or wheezing. Sex and being a child in control cohort 1 or 2 were not significant. 
Incidence rate ratios between cases and the combined control gi'oups are shown 
in Table 14.
Incidence rates were higher for younger children, and more than twofold higher 
during the second half of the year than during the first (Figure 26).
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Figure 1: Incidence rates (95% Cl) of pneumonia (A), wheezing (B), and 
admission for pneumonia or wheezing (C ) by age and season.
The two control cohorts were combined, they were not significantly different from each other 
after adjustment.
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Derived from the model, the point estimates of the incidence rate/100 child years 
for pneumonia in the dry season (Januaiy to June) for 12 months old children 
were 27 for cases, 8.1 for control cohort 1 and 6.5 for control cohort 2. For 
wheezing, the equivalent estimates were 8.4, 0.9, 1.4, respectively. At 3 years of 
age, the incidence rates had fallen to 3.5, 1.1, 0.9 and 0.1, 0.01, 0.01 for the 
three groups and for pneumonia and wheezing, respectively.
The nutritional status of children compared to the NCHS standard varied with 
age, dropping below the standard above half a year of age. However, it was not 
significantly different between the groups.
During the follow up period, 5 children died (1 case, 3 control cohort 1 children, 
and 1 control cohort 2 child).
4.4.1 Discussion
Several studies from developed countries have shown an increased frequency of 
wheeze in children after severe RSV infection. 45,113,132,139,142,154,202,204,225
a study from Qatar showed recurrent wheezing in 42 % of children after RSV 
infection. We have found that wheezing is also significantly more common in 
Gambian children after RSV infection than in controls, but the striking finding in 
our study was the high number of lower respiratory infections without wheeze in 
cases. These were 3 - 4  fold more common in cases than in the control cohorts. 
In addition, all respiratory infections were approximately two times more 
frequent during the second half of the year, which corresponded to the time of 
RSV outbreaks during the study years. Thus, it is possible that about half of the 
respiratory infections during that time, whether with wheeze or without, were
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caused by RSV. A third striking finding fi'om our study is the rapid decline in 
the incidence of respiratory infections with age. Several explanations have been 
brought forward in the past to explain the higher incidence of wheezing after 
RSV infection. They include the suggestion that RSV damages airways and 
therefore leaves children more vulnerable, that RSV induces an atypical 
immune response with an imbalance of Thl and Th2 cells and therefore induces 
asthma, that children with atopy are selected by RSV and therefore
continue to wheeze, or that RSV affects children with smaller airways most 
severely and that RS V only identifies this at-risk group, which continues to 
wheeze. We cannot decide from our study whether RSV was causing 
damage to the airways which led to further infections, or whether RSV infection 
was merely an indicator of an abnormal lung which would have been infected 
more fi^quently afterwards anyhow. However, the r^ id  decline of the incidence 
of all respiratory infections with age indicates that the responsible factor looses 
its influence with increasing age, as would be expected if small airways were the 
responsible factor or if children acquire immunity protecting them, rather than an 
abnormal priming such as atopy or an abnormal Thl/Th2 ratio. The latter would 
be expected to continue unabated or even increase with age.
One of the confusing points in the discussion of the interrelationship between 
RSV infection, asthma and wheezy bronchitis is their identical clinical 
presentation. Wheezy children have a variety of underlying causes. In The 
Gambia, clinically s^arent asthma is relatively rare. In the parallel risk factor 
study, only 4% of mothers of RSV children said they had asthma (see chapter 
4.3). This might explain the r^ id  disappearance of wheezing episodes as a
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clinical problem in all groups, as the development of asthma, based on atopy and 
independent of RSV, does not play as big a role as in industrialised countries.
Our estimates are based on passive case finding, as the guardian had to bring the 
child to MRC for assessment and treatment. The estimates presented are 
therefore likely to be underestimates. It is unlikely, however, that we missed 
many of the more severe events, as free medical care fi’om a doctor at MRC was 
an attractive incentive for parents. Children fiom the case cohort presented more 
frequently for any condition. This could indicate a higher susceptibility to any 
disease in this group, or, more likely, a difference in care seeking behaviour, 
which we have adjusted for in the analysis.
In summary, Gambian children with RSV infection continue to have a higher 
number of respiratory problems than controls over the next 2 years of life. The 
frequency of respiratory problems declines with age, however, and the overall 
long term prognosis of children after RSV infection in The Gambia ^ e a r s  
good.
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Chapter 5. Summary and conclusions
5.1 Findings
In the work presented in this thesis, I have explored the importance of RSV 
infection in The Gambia, West Africa from 1993 to 1996. RSV was sought in 
children under the age of two years admitted to three hospitals in the Western 
Region of The Gambia by immunofluorescence of nasopharyngeal aspirate 
samples. Routine records of all children with ALRI were analysed, and the 
incidence rates of aU ALRI, severe RSV infection, and hypoxaemic RSV 
infection were compared.
In a regression model adjusting for size of village and rural or urban 
environment, the incidence rates of ALRI leading to hospital admission among 
children < 1 year of age living near to the hospitals were estimated to be 11.4 
(95%CI 10.6, 12.3) per hundred children per year for boys and 9.1 (8.4, 9.9) for 
girls living in urban areas. In rural areas incidence rates were 16.1 (14.6,17.6) 
for boys and 12.8 (11.6,14.1) for girls. For severe RSV infection, the incidence 
was 1.3 (1.1,1.6) per hundred children per year for boys, and 1.0 (0.8,1.3) for 
girls, in both urban and rural areas. For hypoxaemic RSV infection, the 
corresponding estimates were 0.1 (0.07,0.19) and 0.07 (0.04,0.13) for boys and 
girls respectively. Correcting for omissions in sampling, the annual incidence of 
ALRI cases admitted to hospital which were due to RSV was estimated to be 
2.6% for boys and 2% for girls; the proportion of all ALRI admissions due to 
RSV was 19%. The median ages of children seen in 1993 to 1996 were 3, 7, 8,
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and 5 months, respectively. Sixty-two percent of children less than 6 months of 
age were boys. Thirteen children (2.4%) had conditions considered to increase 
the risk of severe RSV infection. Eighty (16%) children received oxygen 
because of hypoxaemia. Nine bacterial cultures (7 of 255 blood cultures [2.7%]) 
were positive. Thirteen children died. During the 4 study years, 90%, 25%,
75% and 95% of isolates typed were RSV subgroup A.
In a community study, 25% of children living in compounds of cases and 31% of 
those living in the compounds of controls had evidence of RSV infection during 
the period o f surveillance.
Possible risk factors for severe RSV infection were investigated in a case-control 
study. Two hundred and seventy-seven children admitted to three hospitals in 
the Western Region of the Gambia with an ALRI due to RSV were compared 
with 364 control children matched for age and location of residence who had not 
been admitted to hospital with an ALRI during the RSV season. A detailed 
questionnaire covering a wide range of potential social, environmental and 
nutritional risk factors was administered to the child's guardian. Cases came 
from larger or more crowded compounds than controls; increased risk was 
associated particularly with greater numbers of children in the age group 3-5 
years living in the coirqjound (odds ratio (OR) for 2 or more children in the age 
group 3 to 5 years: 5.67, 95% Cl: 2.8,11.5). Cases had a sibling who had died 
more frequently than controls (OR 2.72, (95%CI 1.4, 5.28). Controls were more 
likely to have been exposed to smoke from cooking fires than cases (OR for the 
mother of cases cooking at least once daily 0.32, 95%CI: 0.15,0.7). Other
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protective factors were father's nationality and some professions. Vegetables 
were included in the diet of controls more frequently than in that of cases (OR 
0.18,95%CI: 0.07,0.48). Mothers of cases complained of asthma more 
frequently than mothers of controls, but the number of asthmatic mothers was 
small (4.2 vs. 0.5%, p=0.05).
To obtain information about the long term respiratory sequelae of severe RSV 
infection, we formed a cohort of 105 children admitted to hospital with RSV 
infection (cases), 105 control children matched for age who had not been 
admitted to hospital with ALRI during the previous RSV season (cohort 1) and 
102 controls who had been bom after the RSV season (cohort 2), and followed 
them prospectively for over 2 years through passive, clinic-based surveillance 
with free access to a physician. The frequencies of pneumonia, wheezing, and 
admission with ALRI were analysed. Using Poisson regression to determine a 
model predicting pneumonia or wheezing, and after adjusting for age, season and 
care seeking behaviour, the incidence rate ratio (95%CI) for pneumonia was 3.80 
(2.73, 6.10), comparing cases with both control cohorts combined. For 
wheezing, the rate ratio was 7.33 (3.10,17.54), for pneumonia or wheezing 3.96 
(2.60, 6.04), and for admission with pneumonia or wheezing 3.40 (1.87, 6.15). 
The point estimates of the incidence rate/100 child years for pneumonia in the 
dry season for 12 month-old children were 27 for cases, 8.1 for control cohort 1 
and 6.51 for control cohort 2. For wheezing, the same estimates were 8.38, 0.88, 
1.41, respectively. At 3 years of age, the incidence rates had fallen to 3.52,1.05,
0.8 and 0.08, 0.01, 0.01 for the three groups and pneumonia and wheezing.
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respectively. Incidence rates were ^proximately twofold higher in the wet 
season.
This series of studies has shown that RSV is a significant cause of lower 
respiratory tract infection in young children in The Gambia, causing yearly 
epidemics of ALRI. It poses a significant burden on the health system, 
especially through the demand for supplementary oxygen. The clinical spectrum 
of RSV infection in The Gambia is similar to that seen in developed countries. 
Addressing potential risk factors is unlikely to be a feasible strategy in the 
control of RSV in The Gambia. Pneumonia and wheezing are significantly more 
common in children after RSV infection than in controls; the incidence is higher 
in the rainy season, and declines rapidly with increasing age.
5.2 Outlook
It was not possible in these studies to assess the importance of RSV as a cause of 
mortality in young children in The Gambia. By the time that a child has been 
diagnosed as having RSV in a hospital, he has overcome the worst risk of dying. 
The question remains as to how many children die before they are admitted to 
hospital. As the RSV season coincides with the malaria season, and because 
both infections can present with similar signs and synq)toms, a randomised 
vaccine trial with an effective vaccine is probably the only way in which this 
issue could be resolved. We have shown that even if RSV is not a major cause 
of death in infancy, morbidity from the infection is considerable, risk factors are 
not easily remediable, and children who have had a severe RSV infection tend to
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have more respiratory problems in the next few years. Thus, on these grounds 
alone a vaccine would be likely to be cost effective in The Gambia and in other 
developing countries where the pattern of RSV infection is similar.
During the period of the study, RSV outbreaks occurred regularly each rainy 
season. However, in 1997, a small outbreak occurred after the end of the rainy 
season. The tim ing of outbreaks of RSV infection appeared to be erratic in 
earlier years also. Knowledge of the seasonality of RSV outbreaks is important 
in the planning of a vaccine trial so that intensive surveillance is instituted during 
the optimum period. In addition, information on seasonality is useful for the 
mathematical modelling of disease dynamics and thus for understanding patterns 
of transmission.
Short of a randomised RSV vaccine teial, documentation of cases of death of 
children in the community and the correlation of deaths with documented RSV 
activity in the same community  would provide some estimate of attributable 
mortality, if the seasonality of RSV infection differs in between years from that 
of malaria, as it was the case in 1997. A large, rural vaccine trial such as the 
proposed trial with a vaccine against S. pneumoniae could provide a vehicle for 
that, if surveillance for RSV was added.
We obtained information on the incidence of respiratory infections in children 
who had experienced a clinically important RSV infection and in controls during 
a period of up to 3 years after their infection (Chuter 4.4). It would be of
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interest to continue follow-up of these children to an age when tests of lung 
function, such as measurement of the size of bronchial airways and the state of 
bronchial responsiveness, could be more readily undertaken and when further 
investigations such as skin tests, tests of T cell function and DNA studies for 
markers of atopy could be done.
If, during these further follow-up studies, abnormal lung function was found 
more frequently in case than in control children, the question will still remain 
open as to whether this was due to a pre-existing abnormality before the RSV 
infection, or whether the case children acquired the abnormalities as a result of 
their RSV infection. This problem could only be resolved definitively by 
recruiting a large cohort of infants at birth, performing a lung function test 
suitable for babies shortly after birth on all children and following them 
longitudinally to dctmnine if they developed an RSV infection and, if so, its 
severity.
A prospective community cohort study would also be desirable to obtain more 
information on the spread of infection in the community, information that would 
be helpful in the planning of a vaccine trial. Ideally, a large number of 
compounds would be recruited and visited at least weekly by a field worker, who 
would document new episodes of respiratoiy infection and obtain a 
nasopharyngeal aspirate sample when this was reported. This would ensure that 
the beginning of an outbreak was not missed. As the sampling does not depend 
on an index child, who might be the last to be infected, reliable estimaies on the
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number of infected children would be obtained, and compounds with children 
with severe infection could be compared with those with müd cases. Serum 
samples obtained at intervals would improve the precision of the estimate, as 
seroconversion could be used in addition to antigen detection.
The Gambia would be a suitable site for some of these further studies, as so 
much information on RSV is available already. However, to improve the global 
view of the importance of RSV, a number of other developing countries or 
agencies interested in child health in these countries should be encouraged to 
undertake more in depth studies on RSV. It is encouraging to know that the 
Global Programme for Vaccines of the World Health Organisation is currently 
supporting studies on RSV epidemiology in several developing countries, 
providing information which should contribute to the knowledge base about this 
virus world-wide Ultimately, it should be possible to control severe respiratory 
disease due to RSV through an effective vaccine.
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